JP2003221386A - 二環性誘導体、その製造法およびその用途 - Google Patents
二環性誘導体、その製造法およびその用途Info
- Publication number
- JP2003221386A JP2003221386A JP2002341477A JP2002341477A JP2003221386A JP 2003221386 A JP2003221386 A JP 2003221386A JP 2002341477 A JP2002341477 A JP 2002341477A JP 2002341477 A JP2002341477 A JP 2002341477A JP 2003221386 A JP2003221386 A JP 2003221386A
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- purity
- retention time
- apci
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000004519 manufacturing process Methods 0.000 title description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 362
- 125000003118 aryl group Chemical group 0.000 claims abstract description 78
- 150000003839 salts Chemical class 0.000 claims abstract description 74
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 70
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 47
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims abstract description 41
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 35
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 34
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 22
- -1 T a is a single bond Chemical group 0.000 claims description 226
- 125000001424 substituent group Chemical group 0.000 claims description 107
- 238000000034 method Methods 0.000 claims description 92
- 239000003814 drug Substances 0.000 claims description 84
- 125000000623 heterocyclic group Chemical group 0.000 claims description 53
- 206010028980 Neoplasm Diseases 0.000 claims description 48
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 34
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 32
- 125000004434 sulfur atom Chemical group 0.000 claims description 30
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 29
- 201000011510 cancer Diseases 0.000 claims description 29
- 229910052717 sulfur Inorganic materials 0.000 claims description 28
- 125000005843 halogen group Chemical group 0.000 claims description 27
- 125000001931 aliphatic group Chemical group 0.000 claims description 23
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 21
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 21
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 16
- 125000002723 alicyclic group Chemical group 0.000 claims description 15
- 229940124597 therapeutic agent Drugs 0.000 claims description 15
- 125000005842 heteroatom Chemical group 0.000 claims description 13
- 229940002612 prodrug Drugs 0.000 claims description 13
- 239000000651 prodrug Substances 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 12
- 206010006187 Breast cancer Diseases 0.000 claims description 10
- 208000026310 Breast neoplasm Diseases 0.000 claims description 10
- 241000124008 Mammalia Species 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 239000012268 protein inhibitor Substances 0.000 claims description 8
- 229940121649 protein inhibitor Drugs 0.000 claims description 8
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 7
- 229910052727 yttrium Inorganic materials 0.000 claims description 7
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 6
- 206010060862 Prostate cancer Diseases 0.000 claims description 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 230000000069 prophylactic effect Effects 0.000 claims description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 201000005202 lung cancer Diseases 0.000 claims description 4
- 208000020816 lung neoplasm Diseases 0.000 claims description 4
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
- 201000002528 pancreatic cancer Diseases 0.000 claims description 4
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 3
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 3
- 229940125782 compound 2 Drugs 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 125000005750 substituted cyclic group Chemical group 0.000 claims 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract description 20
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract description 20
- 230000002401 inhibitory effect Effects 0.000 abstract description 13
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 716
- 230000014759 maintenance of location Effects 0.000 description 713
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 82
- 239000000203 mixture Substances 0.000 description 78
- 235000002639 sodium chloride Nutrition 0.000 description 73
- 239000002904 solvent Substances 0.000 description 67
- 229940079593 drug Drugs 0.000 description 65
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 63
- 230000002829 reductive effect Effects 0.000 description 60
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 53
- 239000000243 solution Substances 0.000 description 53
- 239000007858 starting material Substances 0.000 description 49
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- 238000002360 preparation method Methods 0.000 description 41
- 239000000126 substance Substances 0.000 description 40
- 238000005481 NMR spectroscopy Methods 0.000 description 38
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 38
- 238000001914 filtration Methods 0.000 description 38
- 239000012044 organic layer Substances 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- 239000013078 crystal Substances 0.000 description 37
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 34
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 34
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 238000010898 silica gel chromatography Methods 0.000 description 32
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 27
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 26
- WHQLQYRFIHPMNA-UHFFFAOYSA-N ethyl acetate;oxolane Chemical compound C1CCOC1.CCOC(C)=O WHQLQYRFIHPMNA-UHFFFAOYSA-N 0.000 description 25
- 238000003756 stirring Methods 0.000 description 25
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 24
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 24
- 239000002585 base Substances 0.000 description 23
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 22
- 235000011121 sodium hydroxide Nutrition 0.000 description 21
- 125000003277 amino group Chemical group 0.000 description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 19
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 19
- 238000000746 purification Methods 0.000 description 19
- 238000001953 recrystallisation Methods 0.000 description 19
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 18
- 239000003054 catalyst Substances 0.000 description 18
- 238000002347 injection Methods 0.000 description 18
- 239000007924 injection Substances 0.000 description 18
- 229920006395 saturated elastomer Polymers 0.000 description 18
- 238000009472 formulation Methods 0.000 description 17
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 17
- 230000035484 reaction time Effects 0.000 description 17
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 15
- 235000017557 sodium bicarbonate Nutrition 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 150000001735 carboxylic acids Chemical class 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 14
- 125000000547 substituted alkyl group Chemical group 0.000 description 14
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 13
- 125000003342 alkenyl group Chemical group 0.000 description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 13
- 125000005620 boronic acid group Chemical class 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 229910000029 sodium carbonate Inorganic materials 0.000 description 13
- 235000017550 sodium carbonate Nutrition 0.000 description 13
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 12
- 239000002246 antineoplastic agent Substances 0.000 description 12
- 125000003710 aryl alkyl group Chemical group 0.000 description 12
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 12
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 12
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 12
- 229910000027 potassium carbonate Inorganic materials 0.000 description 12
- 235000011181 potassium carbonates Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 239000008107 starch Substances 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- 238000001356 surgical procedure Methods 0.000 description 12
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 description 11
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 11
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 11
- 230000010261 cell growth Effects 0.000 description 11
- 125000000392 cycloalkenyl group Chemical group 0.000 description 11
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical group C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 11
- 150000002430 hydrocarbons Chemical group 0.000 description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 11
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 11
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 229940088597 hormone Drugs 0.000 description 10
- 239000005556 hormone Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 150000007529 inorganic bases Chemical class 0.000 description 10
- 150000002829 nitrogen Chemical group 0.000 description 10
- 150000007530 organic bases Chemical class 0.000 description 10
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 125000002252 acyl group Chemical group 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 9
- 229910052794 bromium Inorganic materials 0.000 description 9
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 239000008101 lactose Substances 0.000 description 9
- 229940098779 methanesulfonic acid Drugs 0.000 description 9
- 229910052763 palladium Inorganic materials 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- VSCBATMPTLKTOV-UHFFFAOYSA-N 2-tert-butylimino-n,n-diethyl-1,3-dimethyl-1,3,2$l^{5}-diazaphosphinan-2-amine Chemical compound CCN(CC)P1(=NC(C)(C)C)N(C)CCCN1C VSCBATMPTLKTOV-UHFFFAOYSA-N 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 125000000304 alkynyl group Chemical group 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- 238000009833 condensation Methods 0.000 description 8
- 230000005494 condensation Effects 0.000 description 8
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 8
- 239000003102 growth factor Substances 0.000 description 8
- 235000019359 magnesium stearate Nutrition 0.000 description 8
- 239000011736 potassium bicarbonate Substances 0.000 description 8
- 235000015497 potassium bicarbonate Nutrition 0.000 description 8
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 8
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 8
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 8
- 235000011118 potassium hydroxide Nutrition 0.000 description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 229910021515 thallium hydroxide Inorganic materials 0.000 description 8
- QGYXCSSUHCHXHB-UHFFFAOYSA-M thallium(i) hydroxide Chemical compound [OH-].[Tl+] QGYXCSSUHCHXHB-UHFFFAOYSA-M 0.000 description 8
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
- 239000000556 agonist Substances 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 7
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical group CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 7
- 229960004338 leuprorelin Drugs 0.000 description 7
- 125000002950 monocyclic group Chemical group 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 7
- XHQZJYCNDZAGLW-UHFFFAOYSA-N 3-methoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1 XHQZJYCNDZAGLW-UHFFFAOYSA-N 0.000 description 6
- YRGMYJUKFJPNPD-UHFFFAOYSA-N 5-bromopyridine-2,3-diamine Chemical compound NC1=CC(Br)=CN=C1N YRGMYJUKFJPNPD-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 150000001350 alkyl halides Chemical class 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 6
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- 125000001624 naphthyl group Chemical group 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- SANWDQJIWZEKOD-UHFFFAOYSA-N tributyl(furan-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CO1 SANWDQJIWZEKOD-UHFFFAOYSA-N 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- QPBCFQLIGYCRKB-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 QPBCFQLIGYCRKB-UHFFFAOYSA-N 0.000 description 5
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 5
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 5
- 108010000817 Leuprolide Proteins 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 5
- 239000004327 boric acid Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000002170 ethers Chemical class 0.000 description 5
- 229940126864 fibroblast growth factor Drugs 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 150000008282 halocarbons Chemical class 0.000 description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 5
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 125000004076 pyridyl group Chemical group 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 238000013268 sustained release Methods 0.000 description 5
- 239000012730 sustained-release form Substances 0.000 description 5
- 125000001544 thienyl group Chemical group 0.000 description 5
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 4
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 4
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 4
- HNPAYXDHEPQFSV-UHFFFAOYSA-N 3-(6-bromo-1,3-benzoxazol-2-yl)aniline Chemical compound NC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 HNPAYXDHEPQFSV-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 125000005018 aryl alkenyl group Chemical group 0.000 description 4
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 4
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 4
- 125000001589 carboacyl group Chemical group 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 238000010531 catalytic reduction reaction Methods 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 229940022353 herceptin Drugs 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 231100000053 low toxicity Toxicity 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 229920000137 polyphosphoric acid Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 4
- 125000002098 pyridazinyl group Chemical group 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 4
- 229960001860 salicylate Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 3
- MDUQYLQTXOHDAD-UHFFFAOYSA-N 6-bromo-2-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 MDUQYLQTXOHDAD-UHFFFAOYSA-N 0.000 description 3
- UQEYLXNLWAHTFF-UHFFFAOYSA-N 6-bromo-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C1=CC=CC=C1 UQEYLXNLWAHTFF-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 108010037003 Buserelin Proteins 0.000 description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 239000005751 Copper oxide Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000003951 Erythropoietin Human genes 0.000 description 3
- 108090000394 Erythropoietin Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010069236 Goserelin Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 3
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 125000004054 acenaphthylenyl group Chemical group C1(=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000004450 alkenylene group Chemical group 0.000 description 3
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229940043232 butyl acetate Drugs 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 229910000431 copper oxide Inorganic materials 0.000 description 3
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 3
- 238000000315 cryotherapy Methods 0.000 description 3
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 229940127089 cytotoxic agent Drugs 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 229940105423 erythropoietin Drugs 0.000 description 3
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960003690 goserelin acetate Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 3
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229940102223 injectable solution Drugs 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 3
- 238000000608 laser ablation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229960003511 macrogol Drugs 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 125000002757 morpholinyl group Chemical group 0.000 description 3
- BLCLNMBMMGCOAS-UHFFFAOYSA-N n-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amin Chemical compound C1CCC(C(=O)NNC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BLCLNMBMMGCOAS-UHFFFAOYSA-N 0.000 description 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000013546 non-drug therapy Methods 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 239000012434 nucleophilic reagent Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 125000005561 phenanthryl group Chemical group 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- 125000005936 piperidyl group Chemical group 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- WTSKMKRYHATLLL-UHFFFAOYSA-N (6-benzoyloxy-3-cyanopyridin-2-yl) 3-[3-(ethoxymethyl)-5-fluoro-2,6-dioxopyrimidine-1-carbonyl]benzoate Chemical compound O=C1N(COCC)C=C(F)C(=O)N1C(=O)C1=CC=CC(C(=O)OC=2C(=CC=C(OC(=O)C=3C=CC=CC=3)N=2)C#N)=C1 WTSKMKRYHATLLL-UHFFFAOYSA-N 0.000 description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 description 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 2
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 2
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 2
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 2
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 2
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 2
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 2
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 2
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 2
- 125000006039 1-hexenyl group Chemical group 0.000 description 2
- 125000006023 1-pentenyl group Chemical group 0.000 description 2
- 125000006017 1-propenyl group Chemical group 0.000 description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 2
- 125000005955 1H-indazolyl group Chemical group 0.000 description 2
- VSDDIMOPKXUIQF-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 VSDDIMOPKXUIQF-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- IUIMPAZMIAEQGM-UHFFFAOYSA-N 2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]acetic acid Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(O)=O)=C1 IUIMPAZMIAEQGM-UHFFFAOYSA-N 0.000 description 2
- CQEAVAUZWAAFDW-UHFFFAOYSA-N 2-[3-(6-bromo-1,3-benzoxazol-2-yl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 CQEAVAUZWAAFDW-UHFFFAOYSA-N 0.000 description 2
- XRRSVKUNHPQZPE-UHFFFAOYSA-N 2-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]phenol Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)O)=C1 XRRSVKUNHPQZPE-UHFFFAOYSA-N 0.000 description 2
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 2
- 125000006076 2-ethyl-1-butenyl group Chemical group 0.000 description 2
- 125000006040 2-hexenyl group Chemical group 0.000 description 2
- 125000006020 2-methyl-1-propenyl group Chemical group 0.000 description 2
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 2
- 125000006024 2-pentenyl group Chemical group 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- DCOZXTYHDBVBQI-UHFFFAOYSA-N 3-(6-bromo-1,3-benzoxazol-2-yl)benzamide Chemical compound NC(=O)C1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 DCOZXTYHDBVBQI-UHFFFAOYSA-N 0.000 description 2
- NNOBHHQGDQFQRM-UHFFFAOYSA-N 3-(6-bromo-1,3-benzoxazol-2-yl)phenol Chemical compound OC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 NNOBHHQGDQFQRM-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 2
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 2
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 2
- 125000006041 3-hexenyl group Chemical group 0.000 description 2
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 2
- ODOLDBUWAARQFX-UHFFFAOYSA-N 3-nitro-6-phenoxypyridin-2-amine Chemical compound C1=C([N+]([O-])=O)C(N)=NC(OC=2C=CC=CC=2)=C1 ODOLDBUWAARQFX-UHFFFAOYSA-N 0.000 description 2
- XBWMSLRYGXSAKH-UHFFFAOYSA-N 3-nitro-6-phenylpyridin-2-amine Chemical compound C1=C([N+]([O-])=O)C(N)=NC(C=2C=CC=CC=2)=C1 XBWMSLRYGXSAKH-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 2
- GSAWEEWOTMFBSL-UHFFFAOYSA-N 4-[2-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 GSAWEEWOTMFBSL-UHFFFAOYSA-N 0.000 description 2
- 125000006042 4-hexenyl group Chemical group 0.000 description 2
- 125000003119 4-methyl-3-pentenyl group Chemical group [H]\C(=C(/C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- KUFSSJUDMWCDJV-FPYGCLRLSA-N 5-bromo-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC(Br)=CC=C2O1 KUFSSJUDMWCDJV-FPYGCLRLSA-N 0.000 description 2
- HEWVHZGAFPHCKG-RMKNXTFCSA-N 5-bromo-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC(Br)=CC=C2OC=1\C=C\C1=CC=CC=C1 HEWVHZGAFPHCKG-RMKNXTFCSA-N 0.000 description 2
- 125000006043 5-hexenyl group Chemical group 0.000 description 2
- KCSXIWGRTDIEPT-UHFFFAOYSA-N 6-bromo-2-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 KCSXIWGRTDIEPT-UHFFFAOYSA-N 0.000 description 2
- CVWLLDUOBZSXNY-UHFFFAOYSA-N 6-bromo-2-(3-nitrophenyl)-1,3-benzoxazole Chemical compound [O-][N+](=O)C1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 CVWLLDUOBZSXNY-UHFFFAOYSA-N 0.000 description 2
- RKQHXLHGBLLUGJ-UHFFFAOYSA-N 6-bromo-2-[(3,4-dimethoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 RKQHXLHGBLLUGJ-UHFFFAOYSA-N 0.000 description 2
- WERABQRUGJIMKQ-UHFFFAOYSA-N 6-chloro-3-nitropyridin-2-amine Chemical compound NC1=NC(Cl)=CC=C1[N+]([O-])=O WERABQRUGJIMKQ-UHFFFAOYSA-N 0.000 description 2
- RQQXCKHRBSAFHJ-UHFFFAOYSA-N 6-phenoxypyridine-2,3-diamine Chemical compound N1=C(N)C(N)=CC=C1OC1=CC=CC=C1 RQQXCKHRBSAFHJ-UHFFFAOYSA-N 0.000 description 2
- KWEKGHLBYYNQBW-UHFFFAOYSA-N 6-phenylpyridine-2,3-diamine Chemical compound N1=C(N)C(N)=CC=C1C1=CC=CC=C1 KWEKGHLBYYNQBW-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 2
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 208000007766 Kaposi sarcoma Diseases 0.000 description 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229910052770 Uranium Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 125000004419 alkynylene group Chemical group 0.000 description 2
- 229950010949 ambamustine Drugs 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 125000002078 anthracen-1-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([*])=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 2
- 125000000748 anthracen-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([H])=C([*])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000002393 azetidinyl group Chemical group 0.000 description 2
- 125000003828 azulenyl group Chemical group 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 229960002719 buserelin Drugs 0.000 description 2
- CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 2
- 125000005569 butenylene group Chemical group 0.000 description 2
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 229940000425 combination drug Drugs 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 125000005724 cycloalkenylene group Chemical group 0.000 description 2
- 125000002993 cycloalkylene group Chemical group 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 229950005450 emitefur Drugs 0.000 description 2
- XPGDODOEEWLHOI-GSDHBNRESA-N ethyl (2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-fluorophenyl)propanoyl]amino]-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-4-methylsulfanylbutanoate Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)OCC)NC(=O)[C@@H](N)CC=1C=CC(F)=CC=1)C1=CC=CC(N(CCCl)CCCl)=C1 XPGDODOEEWLHOI-GSDHBNRESA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 2
- 229940080856 gleevec Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 125000003427 indacenyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000002601 intratumoral effect Effects 0.000 description 2
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 2
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 2
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 2
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 2
- 125000005956 isoquinolyl group Chemical group 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- GPSDUZXPYCFOSQ-UHFFFAOYSA-N m-toluic acid Chemical compound CC1=CC=CC(C(O)=O)=C1 GPSDUZXPYCFOSQ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960004961 mechlorethamine Drugs 0.000 description 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
- 229960003194 meglumine Drugs 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 125000005394 methallyl group Chemical group 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 2
- 229940053128 nerve growth factor Drugs 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 2
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 2
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 2
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 2
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 108010001062 polysaccharide-K Proteins 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- 125000005493 quinolyl group Chemical group 0.000 description 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 2
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 125000005017 substituted alkenyl group Chemical group 0.000 description 2
- 125000004426 substituted alkynyl group Chemical group 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 239000007940 sugar coated tablet Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000006068 taste-masking agent Substances 0.000 description 2
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000002053 thietanyl group Chemical group 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229960000575 trastuzumab Drugs 0.000 description 2
- 125000004306 triazinyl group Chemical group 0.000 description 2
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical class CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 125000004933 β-carbolinyl group Chemical group C1(=NC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- NAALWFYYHHJEFQ-ZASNTINBSA-N (2s,5r,6r)-6-[[(2r)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1h-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC(O)=CC=1)C(=O)C(C(N1)=O)=CC=C1C1=CC=C(S(=O)(=O)N(CCO)CCO)C=C1 NAALWFYYHHJEFQ-ZASNTINBSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- SVSFIELZISOJDT-XRZFDKQNSA-N (6r,7r)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride Chemical compound Cl.CN(C)CCN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC=3N=C(N)SC=3)[C@H]2SC1 SVSFIELZISOJDT-XRZFDKQNSA-N 0.000 description 1
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 description 1
- ZPHYPKKFSHAVOE-YZIXBPQXSA-N (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-6-methyl-5-[(2r)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@@H]1CCCCO1 ZPHYPKKFSHAVOE-YZIXBPQXSA-N 0.000 description 1
- FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 1
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- MJUVRTYWUMPBTR-MRXNPFEDSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide Chemical compound FC=1C=C2N(C[C@@H](O)CO)C(C(C)(CO)C)=CC2=CC=1NC(=O)C1(C=2C=C3OC(F)(F)OC3=CC=2)CC1 MJUVRTYWUMPBTR-MRXNPFEDSA-N 0.000 description 1
- AHLZFBDNWMOZLM-UHFFFAOYSA-N 1-(2-methoxyethyl)-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound C1=C2N(CCOC)C(C=3C=C(OC)C=CC=3)=NC2=NC=C1C1=CC=CC=C1 AHLZFBDNWMOZLM-UHFFFAOYSA-N 0.000 description 1
- BHMCJGLDLTYBBK-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]ethanone Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(=O)C=2C=CC(Cl)=CC=2)=C1 BHMCJGLDLTYBBK-UHFFFAOYSA-N 0.000 description 1
- XWZVRVRKHBOAIB-UHFFFAOYSA-N 1-(4-methoxyphenyl)-2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]ethanone Chemical compound C1=CC(OC)=CC=C1C(=O)CN1C2=CC(C=3C=CC=CC=3)=CN=C2N=C1C1=CC=CC(OC)=C1 XWZVRVRKHBOAIB-UHFFFAOYSA-N 0.000 description 1
- KJQMDQDQXJDXJR-UHFFFAOYSA-N 1-(4-pentoxyphenyl)ethanone Chemical compound CCCCCOC1=CC=C(C(C)=O)C=C1 KJQMDQDQXJDXJR-UHFFFAOYSA-N 0.000 description 1
- GJHMHBSURWQIRX-UHFFFAOYSA-N 1-(9h-fluoren-9-yl)-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)C2C3=CC=CC=C3C3=CC=CC=C32)=C1 GJHMHBSURWQIRX-UHFFFAOYSA-N 0.000 description 1
- IZXWCDITFDNEBY-UHFFFAOYSA-N 1-(chloromethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CCl)C=C1 IZXWCDITFDNEBY-UHFFFAOYSA-N 0.000 description 1
- STKCXAMDBKOENL-UHFFFAOYSA-N 1-(cyclohexylmethyl)-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC2CCCCC2)=C1 STKCXAMDBKOENL-UHFFFAOYSA-N 0.000 description 1
- XUZGMZFTCCGOSG-UHFFFAOYSA-N 1-(cyclopropylmethyl)-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC2CC2)=C1 XUZGMZFTCCGOSG-UHFFFAOYSA-N 0.000 description 1
- WMGODZOHRTVLIK-UHFFFAOYSA-N 1-(cyclopropylmethyl)-2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CC1CC1 WMGODZOHRTVLIK-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- KTENYMNLXPKTTG-UHFFFAOYSA-N 1-[(2,4-difluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC(F)=CC=2)F)=C1 KTENYMNLXPKTTG-UHFFFAOYSA-N 0.000 description 1
- QESBCSAHBUWYCT-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2F)F)=C1 QESBCSAHBUWYCT-UHFFFAOYSA-N 0.000 description 1
- RZYNOUXKJLKIHV-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)Cl)=C1 RZYNOUXKJLKIHV-UHFFFAOYSA-N 0.000 description 1
- XUDUWVVSZRQRNP-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)F)=C1 XUDUWVVSZRQRNP-UHFFFAOYSA-N 0.000 description 1
- YKMXJYRCJOJHHE-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(Cl)C(Cl)=CC=2)=C1 YKMXJYRCJOJHHE-UHFFFAOYSA-N 0.000 description 1
- HGPRGMLKQVMPDP-UHFFFAOYSA-N 1-[(3,4-dimethylphenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(C)C(C)=CC=2)=C1 HGPRGMLKQVMPDP-UHFFFAOYSA-N 0.000 description 1
- NIRLHBSAZIORCM-UHFFFAOYSA-N 1-[(3,5-difluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(F)C=C(F)C=2)=C1 NIRLHBSAZIORCM-UHFFFAOYSA-N 0.000 description 1
- JFEJHDCHWFRHSW-UHFFFAOYSA-N 1-[(3,5-dimethoxyphenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(OC)C=C(OC)C=2)=C1 JFEJHDCHWFRHSW-UHFFFAOYSA-N 0.000 description 1
- AZBWTGSPGLIYJR-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(F)C=CC=2)=C1 AZBWTGSPGLIYJR-UHFFFAOYSA-N 0.000 description 1
- VBYSFWNQRWFFBH-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(F)=CC=2)=C1 VBYSFWNQRWFFBH-UHFFFAOYSA-N 0.000 description 1
- UHRSBIQLEIFHFX-UHFFFAOYSA-N 1-[(4-tert-butylphenyl)methyl]-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)C(C)(C)C)=C1 UHRSBIQLEIFHFX-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- GJQWQDGIOMSUSX-UHFFFAOYSA-N 1-[2-[2-(3-methoxyphenyl)-1,3-benzoxazol-5-yl]phenyl]ethanone Chemical compound COC1=CC=CC(C=2OC3=CC=C(C=C3N=2)C=2C(=CC=CC=2)C(C)=O)=C1 GJQWQDGIOMSUSX-UHFFFAOYSA-N 0.000 description 1
- KTGQGKRSQODOHE-UHFFFAOYSA-N 1-[2-[2-(phenoxymethyl)-1h-imidazo[4,5-b]pyridin-6-yl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1C1=CN=C(N=C(COC=2C=CC=CC=2)N2)C2=C1 KTGQGKRSQODOHE-UHFFFAOYSA-N 0.000 description 1
- LTECJZFDSKAIRK-UHFFFAOYSA-N 1-[2-[2-[(3,4-dimethoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridin-6-yl]phenyl]ethanone Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3C(=CC=CC=3)C(C)=O)C=C2N1 LTECJZFDSKAIRK-UHFFFAOYSA-N 0.000 description 1
- NLDYKQYCEINKSS-DHZHZOJOSA-N 1-[2-[2-[(e)-2-(2,4-difluorophenyl)ethenyl]-1,3-benzoxazol-5-yl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1C1=CC=C(OC(\C=C\C=2C(=CC(F)=CC=2)F)=N2)C2=C1 NLDYKQYCEINKSS-DHZHZOJOSA-N 0.000 description 1
- SFACBIZEJKTDBZ-SDNWHVSQSA-N 1-[2-[2-[(e)-2-phenylethenyl]-1,3-benzoxazol-5-yl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1C1=CC=C(OC(\C=C\C=2C=CC=CC=2)=N2)C2=C1 SFACBIZEJKTDBZ-SDNWHVSQSA-N 0.000 description 1
- OXLZJWOWYCIIJA-VAWYXSNFSA-N 1-[2-[2-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridin-6-yl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1C1=CN=C(N=C(\C=C\C=2C=CC=CC=2)N2)C2=C1 OXLZJWOWYCIIJA-VAWYXSNFSA-N 0.000 description 1
- JARHXRYMZCBAPZ-UHFFFAOYSA-N 1-[3-(6-bromo-1,3-benzoxazol-2-yl)phenyl]-3-ethylurea Chemical compound CCNC(=O)NC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 JARHXRYMZCBAPZ-UHFFFAOYSA-N 0.000 description 1
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 1
- PPZYXXNJNFQGKL-UHFFFAOYSA-N 1-benzhydryl-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 PPZYXXNJNFQGKL-UHFFFAOYSA-N 0.000 description 1
- SHABMDYBYNCWFJ-UHFFFAOYSA-N 1-decyl-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound C1=C2N(CCCCCCCCCC)C(C=3C=C(OC)C=CC=3)=NC2=NC=C1C1=CC=CC=C1 SHABMDYBYNCWFJ-UHFFFAOYSA-N 0.000 description 1
- DHAOUDJTHYVTQA-UHFFFAOYSA-N 1-ethyl-2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound C1=C2N(CC)C(C=3C=C(OC)C=CC=3)=NC2=NC=C1C1=CC=CC=C1 DHAOUDJTHYVTQA-UHFFFAOYSA-N 0.000 description 1
- BZNZAUUFVZJKHM-UHFFFAOYSA-N 1-ethyl-3-[3-[6-(2-fluorophenyl)-1,3-benzoxazol-2-yl]phenyl]urea Chemical compound CCNC(=O)NC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 BZNZAUUFVZJKHM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- DGHHQBMTXTWTJV-BQAIUKQQSA-N 119413-54-6 Chemical compound Cl.C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 DGHHQBMTXTWTJV-BQAIUKQQSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- HYPDFWGITZNESS-SIDAKMONSA-N 2,5-bis[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC(\C=C\C=3C=CC=CC=3)=CC=C2OC=1/C=C/C1=CC=CC=C1 HYPDFWGITZNESS-SIDAKMONSA-N 0.000 description 1
- YKKBIOVBMRLZFX-UHFFFAOYSA-N 2,6-bis(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C=C(OC)C=CC=2)=C1 YKKBIOVBMRLZFX-UHFFFAOYSA-N 0.000 description 1
- IXRZJQUKBZTTIQ-UHFFFAOYSA-N 2,6-bis(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(OC)C=CC=2)=C1 IXRZJQUKBZTTIQ-UHFFFAOYSA-N 0.000 description 1
- MHEDTBRUZVMXDN-LDHFCIDVSA-N 2,6-bis[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(\C=C\C=3C=CC=CC=3)C=C2NC=1/C=C/C1=CC=CC=C1 MHEDTBRUZVMXDN-LDHFCIDVSA-N 0.000 description 1
- SRCFAFTYCRBLIZ-UHFFFAOYSA-N 2,6-diphenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 SRCFAFTYCRBLIZ-UHFFFAOYSA-N 0.000 description 1
- GETVMPNWWWZLEZ-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C4OCOC4=CC=3)C2=C1 GETVMPNWWWZLEZ-UHFFFAOYSA-N 0.000 description 1
- HCTQIKAIBSQQBY-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C3OCOC3=CC=2)=C1 HCTQIKAIBSQQBY-UHFFFAOYSA-N 0.000 description 1
- WEGNPETVWLJHOR-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(N2)C=3C=C4OCOC4=CC=3)C2=C1 WEGNPETVWLJHOR-UHFFFAOYSA-N 0.000 description 1
- WTAJHLUKVVLGEM-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C3OCOC3=CC=2)=C1 WTAJHLUKVVLGEM-UHFFFAOYSA-N 0.000 description 1
- OFJZZFVETYLMKQ-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-bromo-1h-imidazo[4,5-b]pyridine Chemical compound C1=C2OCOC2=CC(C2=NC3=NC=C(C=C3N2)Br)=C1 OFJZZFVETYLMKQ-UHFFFAOYSA-N 0.000 description 1
- FCIHYOVXWJCRJY-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=C2C(C3=CN=C4N=C(NC4=C3)C3=CC=C4OCOC4=C3)=CC=CC2=C1 FCIHYOVXWJCRJY-UHFFFAOYSA-N 0.000 description 1
- BMVMKEBEHCBXPT-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C2OCOC2=CC=C1C(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 BMVMKEBEHCBXPT-UHFFFAOYSA-N 0.000 description 1
- YQGCRDUSROZFLF-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-ylmethyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=C2OCOC2=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 YQGCRDUSROZFLF-UHFFFAOYSA-N 0.000 description 1
- LKPJRTPYQBBOEC-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-ylmethyl)-6-bromo-1h-imidazo[4,5-b]pyridine Chemical compound C1=C2OCOC2=CC(CC2=NC3=NC=C(C=C3N2)Br)=C1 LKPJRTPYQBBOEC-UHFFFAOYSA-N 0.000 description 1
- WTBQXRSTEBBQKS-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3OC4=CC=CC=C4C=3)C2=C1 WTBQXRSTEBBQKS-UHFFFAOYSA-N 0.000 description 1
- SQISUNFMCNVFHZ-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=COC(C=2C=C3OC(=NC3=CC=2)C=2OC3=CC=CC=C3C=2)=C1 SQISUNFMCNVFHZ-UHFFFAOYSA-N 0.000 description 1
- FHUSQNYNUZPGCT-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3SC4=CC=CC=C4C=3)C2=C1 FHUSQNYNUZPGCT-UHFFFAOYSA-N 0.000 description 1
- XRYUOENTOGLORH-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=COC(C=2C=C3OC(=NC3=CC=2)C=2SC3=CC=CC=C3C=2)=C1 XRYUOENTOGLORH-UHFFFAOYSA-N 0.000 description 1
- CBSVOZDFQPZELH-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)-6-bromo-1,3-benzoxazole Chemical compound C1=CC=C2SC(C3=NC4=CC=C(C=C4O3)Br)=CC2=C1 CBSVOZDFQPZELH-UHFFFAOYSA-N 0.000 description 1
- PQOMVRUZBCUYLL-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(CCC2CCCC2)N2)C2=C1 PQOMVRUZBCUYLL-UHFFFAOYSA-N 0.000 description 1
- JIAFDGGUOJLAMC-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(CCC2CCCC2)N2)C2=C1 JIAFDGGUOJLAMC-UHFFFAOYSA-N 0.000 description 1
- NQERTKZLBCMCJA-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCC1CCC(NC1=C2)=NC1=NC=C2C1=CC=CO1 NQERTKZLBCMCJA-UHFFFAOYSA-N 0.000 description 1
- RFIGIMIVGPUISZ-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C=C3NC(CCC4CCCC4)=NC3=NC=2)=C1 RFIGIMIVGPUISZ-UHFFFAOYSA-N 0.000 description 1
- USHIPQBXBJTVFK-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2NC=1CCC1CCCC1 USHIPQBXBJTVFK-UHFFFAOYSA-N 0.000 description 1
- IYJOYSIXICUNEV-UHFFFAOYSA-N 2-(2-cyclopentylethyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCC1CCC(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 IYJOYSIXICUNEV-UHFFFAOYSA-N 0.000 description 1
- ZZIZZTHXZRDOFM-UHFFFAOYSA-N 2-(2-ethoxyphenoxy)ethyl-[1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl]azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-UHFFFAOYSA-N 0.000 description 1
- LZFNNGXVZUQMHU-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C(=CC=CC=3)F)C2=C1 LZFNNGXVZUQMHU-UHFFFAOYSA-N 0.000 description 1
- HRBFPBPULPUDBK-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C(=CC=CC=2)F)=C1 HRBFPBPULPUDBK-UHFFFAOYSA-N 0.000 description 1
- DMQKAENCFFWNJN-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 DMQKAENCFFWNJN-UHFFFAOYSA-N 0.000 description 1
- NKTUGBIKOJOYCQ-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 NKTUGBIKOJOYCQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- YGJDBLNXILNCTB-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C(=CC=CC=2)OC)=C1 YGJDBLNXILNCTB-UHFFFAOYSA-N 0.000 description 1
- BQPABTDVTFBWOD-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C(=CC=CC=2)OC)=C1 BQPABTDVTFBWOD-UHFFFAOYSA-N 0.000 description 1
- MZHUOJMTSHVGEN-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C=CC(=CC=3)S(C)(=O)=O)C=C2N1 MZHUOJMTSHVGEN-UHFFFAOYSA-N 0.000 description 1
- CJANLBJOVFYUIC-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C=C(C=CC=3)C(F)(F)F)C=C2N1 CJANLBJOVFYUIC-UHFFFAOYSA-N 0.000 description 1
- OYQMHPIWQTZYAA-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 OYQMHPIWQTZYAA-UHFFFAOYSA-N 0.000 description 1
- PMEJZQDDWUAMML-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 PMEJZQDDWUAMML-UHFFFAOYSA-N 0.000 description 1
- WWVQVNDFBGBQEH-UHFFFAOYSA-N 2-(2-methyl-3-propan-2-yloxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1C WWVQVNDFBGBQEH-UHFFFAOYSA-N 0.000 description 1
- QLYHDVUBSRBJHA-UHFFFAOYSA-N 2-(2-phenylethyl)-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3SC=CC=3)C=C2NC=1CCC1=CC=CC=C1 QLYHDVUBSRBJHA-UHFFFAOYSA-N 0.000 description 1
- ZCRXUSZYMKRSHD-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)F)C=C2O1 ZCRXUSZYMKRSHD-UHFFFAOYSA-N 0.000 description 1
- IQSDEQMTOSJPRK-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-6-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(OC)C(OC)=CC=2)=C1 IQSDEQMTOSJPRK-UHFFFAOYSA-N 0.000 description 1
- JDUXVUKYTRWLLK-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 JDUXVUKYTRWLLK-UHFFFAOYSA-N 0.000 description 1
- APNANZZEJYCAQE-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)C(F)(F)F)C=C2O1 APNANZZEJYCAQE-UHFFFAOYSA-N 0.000 description 1
- WUIRSIZVNAYBER-UHFFFAOYSA-N 2-(3,5-difluorophenyl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 WUIRSIZVNAYBER-UHFFFAOYSA-N 0.000 description 1
- DDBODDORLSLXIX-UHFFFAOYSA-N 2-(3-but-3-enoxyphenyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OCCC=C)C=CC=3)C2=C1 DDBODDORLSLXIX-UHFFFAOYSA-N 0.000 description 1
- IVJMUWLZDPRFQI-UHFFFAOYSA-N 2-(3-but-3-enoxyphenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C=CCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 IVJMUWLZDPRFQI-UHFFFAOYSA-N 0.000 description 1
- SHXRZMFKQOOVNN-UHFFFAOYSA-N 2-(3-but-3-enoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C=CCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 SHXRZMFKQOOVNN-UHFFFAOYSA-N 0.000 description 1
- ACTSAFYODRJXRL-UHFFFAOYSA-N 2-(3-butoxyphenyl)-1-(cyclopropylmethyl)-6-(furan-2-yl)imidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)CC2CC2)=C1 ACTSAFYODRJXRL-UHFFFAOYSA-N 0.000 description 1
- DKGWUMFNLIWLTN-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 DKGWUMFNLIWLTN-UHFFFAOYSA-N 0.000 description 1
- JMDORQPBSSZWLP-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound CCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 JMDORQPBSSZWLP-UHFFFAOYSA-N 0.000 description 1
- HBOIEEODRZSMJD-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(furan-2-yl)-1-(2-methoxyethyl)imidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)CCOC)=C1 HBOIEEODRZSMJD-UHFFFAOYSA-N 0.000 description 1
- KGVGTSBBMNWQJH-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(furan-2-yl)-1-methylimidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)C)=C1 KGVGTSBBMNWQJH-UHFFFAOYSA-N 0.000 description 1
- QRRTUJIPNFJLQU-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(furan-2-yl)-1-pent-4-enylimidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)CCCC=C)=C1 QRRTUJIPNFJLQU-UHFFFAOYSA-N 0.000 description 1
- FAYCSTWDOMAPOJ-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 FAYCSTWDOMAPOJ-UHFFFAOYSA-N 0.000 description 1
- IVXVUYHNRLFABY-UHFFFAOYSA-N 2-(3-butoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CCCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 IVXVUYHNRLFABY-UHFFFAOYSA-N 0.000 description 1
- PWBULNZVXRNIJC-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(Cl)C=CC=3)C2=C1 PWBULNZVXRNIJC-UHFFFAOYSA-N 0.000 description 1
- DTPKDGYINHKWRR-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C(Cl)C=CC=2)=C1 DTPKDGYINHKWRR-UHFFFAOYSA-N 0.000 description 1
- CHRRNGBUABSMLW-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(N2)C=3C=C(Cl)C=CC=3)C2=C1 CHRRNGBUABSMLW-UHFFFAOYSA-N 0.000 description 1
- ZKPNSYXQIZRXPG-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 ZKPNSYXQIZRXPG-UHFFFAOYSA-N 0.000 description 1
- NKTSXXVAJFDTHS-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C(Cl)C=CC=2)=C1 NKTSXXVAJFDTHS-UHFFFAOYSA-N 0.000 description 1
- KGWPRTBLOARSFL-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C3=CC=CC=C3C=CC=2)=C1 KGWPRTBLOARSFL-UHFFFAOYSA-N 0.000 description 1
- WXLNFFIXWJWVBQ-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 WXLNFFIXWJWVBQ-UHFFFAOYSA-N 0.000 description 1
- RUJRPUKSMJASKN-UHFFFAOYSA-N 2-(3-cyclopentyloxyphenyl)-6-(2,4-difluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1C1=CC=C(N=C(O2)C=3C=C(OC4CCCC4)C=CC=3)C2=C1 RUJRPUKSMJASKN-UHFFFAOYSA-N 0.000 description 1
- MDUYRIQAOQKPBL-UHFFFAOYSA-N 2-(3-cyclopentyloxyphenyl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(OC4CCCC4)C=CC=3)C2=C1 MDUYRIQAOQKPBL-UHFFFAOYSA-N 0.000 description 1
- DBDFDGZDQVVMAV-UHFFFAOYSA-N 2-(3-cyclopentyloxyphenyl)-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OC4CCCC4)C=CC=3)C2=C1 DBDFDGZDQVVMAV-UHFFFAOYSA-N 0.000 description 1
- OIODWLIXYZIIIS-UHFFFAOYSA-N 2-(3-cyclopentyloxyphenyl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1CCCC1OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 OIODWLIXYZIIIS-UHFFFAOYSA-N 0.000 description 1
- KVNYQCZHVIEVRO-UHFFFAOYSA-N 2-(3-cyclopentyloxyphenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCC1OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 KVNYQCZHVIEVRO-UHFFFAOYSA-N 0.000 description 1
- DDDQYXXPVWHIFK-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound CCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 DDDQYXXPVWHIFK-UHFFFAOYSA-N 0.000 description 1
- KYXUTMQWKNIBII-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound CCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 KYXUTMQWKNIBII-UHFFFAOYSA-N 0.000 description 1
- XYDFYZYPKLBEKF-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 XYDFYZYPKLBEKF-UHFFFAOYSA-N 0.000 description 1
- DNTMRAPSIVQYLI-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 DNTMRAPSIVQYLI-UHFFFAOYSA-N 0.000 description 1
- WYQHTYORGJTCEH-UHFFFAOYSA-N 2-(3-ethylphenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound CCC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 WYQHTYORGJTCEH-UHFFFAOYSA-N 0.000 description 1
- XALJJHYMWPTSFL-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(F)C=CC=3)C2=C1 XALJJHYMWPTSFL-UHFFFAOYSA-N 0.000 description 1
- WMODBDGRQKSBSV-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(F)C=CC=2)=C1 WMODBDGRQKSBSV-UHFFFAOYSA-N 0.000 description 1
- PEGZXCLBFRRDLW-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C(F)C=CC=2)=C1 PEGZXCLBFRRDLW-UHFFFAOYSA-N 0.000 description 1
- FMVMZAQJPPKVAD-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 FMVMZAQJPPKVAD-UHFFFAOYSA-N 0.000 description 1
- VVLRSFFCKBDRJZ-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 VVLRSFFCKBDRJZ-UHFFFAOYSA-N 0.000 description 1
- VSRIJUGIFLCYMW-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 VSRIJUGIFLCYMW-UHFFFAOYSA-N 0.000 description 1
- UNYFFHKJKBVXIS-UHFFFAOYSA-N 2-(3-fluorophenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 UNYFFHKJKBVXIS-UHFFFAOYSA-N 0.000 description 1
- SAUNPGUMBJWCKR-UHFFFAOYSA-N 2-(3-hexoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CCCCCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 SAUNPGUMBJWCKR-UHFFFAOYSA-N 0.000 description 1
- XAIZXHLFSKRDFC-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-(2-methylpropyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(C)C)=C1 XAIZXHLFSKRDFC-UHFFFAOYSA-N 0.000 description 1
- VRJRBKCIAIALNO-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-(3-phenoxypropyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCCOC=2C=CC=CC=2)=C1 VRJRBKCIAIALNO-UHFFFAOYSA-N 0.000 description 1
- BONSJPMFXNUTHE-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-(naphthalen-1-ylmethyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C3=CC=CC=C3C=CC=2)=C1 BONSJPMFXNUTHE-UHFFFAOYSA-N 0.000 description 1
- VHWSBAPACWZETB-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-(naphthalen-2-ylmethyl)-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C3C=CC=CC3=CC=2)=C1 VHWSBAPACWZETB-UHFFFAOYSA-N 0.000 description 1
- VGLTYHDKUPCJPD-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(2-methylphenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)C)=C1 VGLTYHDKUPCJPD-UHFFFAOYSA-N 0.000 description 1
- FYJKHRGHWRCXRD-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(2-nitrophenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)[N+]([O-])=O)=C1 FYJKHRGHWRCXRD-UHFFFAOYSA-N 0.000 description 1
- DPTKIRLOLDOLLK-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(3-methoxyphenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CN2C3=CC(=CN=C3N=C2C=2C=C(OC)C=CC=2)C=2C=CC=CC=2)=C1 DPTKIRLOLDOLLK-UHFFFAOYSA-N 0.000 description 1
- DTCHOVMIXCDDFH-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(3-nitrophenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(C=CC=2)[N+]([O-])=O)=C1 DTCHOVMIXCDDFH-UHFFFAOYSA-N 0.000 description 1
- MYBBZYKEKSFHJA-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(3-phenoxyphenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(OC=3C=CC=CC=3)C=CC=2)=C1 MYBBZYKEKSFHJA-UHFFFAOYSA-N 0.000 description 1
- LDTUIPWUECSRGX-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(4-methoxyphenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CN1C2=CC(C=3C=CC=CC=3)=CN=C2N=C1C1=CC=CC(OC)=C1 LDTUIPWUECSRGX-UHFFFAOYSA-N 0.000 description 1
- DWSPVTLFOLLWAW-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(4-methylphenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(C)=CC=2)=C1 DWSPVTLFOLLWAW-UHFFFAOYSA-N 0.000 description 1
- WRQGWFNBHKMXKP-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-[(4-nitrophenyl)methyl]-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)[N+]([O-])=O)=C1 WRQGWFNBHKMXKP-UHFFFAOYSA-N 0.000 description 1
- POLAIMHOTRRLOQ-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1-pent-4-enyl-6-phenylimidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCCC=C)=C1 POLAIMHOTRRLOQ-UHFFFAOYSA-N 0.000 description 1
- FZOXZQVQCBBONX-ZHACJKMWSA-N 2-(3-methoxyphenyl)-5-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC=C(\C=C\C=4C=CC=CC=4)C=C3N=2)=C1 FZOXZQVQCBBONX-ZHACJKMWSA-N 0.000 description 1
- SNGVZUOHVBHICG-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5-phenoxy-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC=C(OC=4C=CC=CC=4)N=C3N=2)=C1 SNGVZUOHVBHICG-UHFFFAOYSA-N 0.000 description 1
- ZBIGZWSYBBPOLU-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5-phenyl-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC=C(C=C3N=2)C=2C=CC=CC=2)=C1 ZBIGZWSYBBPOLU-UHFFFAOYSA-N 0.000 description 1
- UUWVQTCPWKNBAI-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5-pyridin-3-yl-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC=C(C=C3N=2)C=2C=NC=CC=2)=C1 UUWVQTCPWKNBAI-UHFFFAOYSA-N 0.000 description 1
- RGGQOZAVLZBMAO-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 RGGQOZAVLZBMAO-UHFFFAOYSA-N 0.000 description 1
- JLKIXZGHYXQKMQ-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 JLKIXZGHYXQKMQ-UHFFFAOYSA-N 0.000 description 1
- MWRRMBUJLFFTFC-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(C=CC=2)C(F)(F)F)=C1 MWRRMBUJLFFTFC-UHFFFAOYSA-N 0.000 description 1
- BNGKIARHXPMECI-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C3=CC=CC=C3C=CC=2)=C1 BNGKIARHXPMECI-UHFFFAOYSA-N 0.000 description 1
- LKQPNVSYMARFJA-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C=CC=CC=2)=C1 LKQPNVSYMARFJA-UHFFFAOYSA-N 0.000 description 1
- FCYWNLDQPVCCHX-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-(2-phenylethyl)imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCC=2C=CC=CC=2)=C1 FCYWNLDQPVCCHX-UHFFFAOYSA-N 0.000 description 1
- JAXLMHJEQSHITE-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-(pyridin-3-ylmethyl)imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=NC=CC=2)=C1 JAXLMHJEQSHITE-UHFFFAOYSA-N 0.000 description 1
- UEEOJMRQNISQFE-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-(pyridin-4-ylmethyl)imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CN=CC=2)=C1 UEEOJMRQNISQFE-UHFFFAOYSA-N 0.000 description 1
- ZKUWSUYFXQPAIZ-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[(2-phenylphenyl)methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)C=2C=CC=CC=2)=C1 ZKUWSUYFXQPAIZ-UHFFFAOYSA-N 0.000 description 1
- PYYVGFYETRKFSS-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[(4-phenylphenyl)methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)C=2C=CC=CC=2)=C1 PYYVGFYETRKFSS-UHFFFAOYSA-N 0.000 description 1
- DKOQEGGQOJIJQL-FMIVXFBMSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[(e)-3-phenylprop-2-enyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)C\C=C\C=2C=CC=CC=2)=C1 DKOQEGGQOJIJQL-FMIVXFBMSA-N 0.000 description 1
- PFMPCBMZQGVWNK-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[[2-(trifluoromethyl)phenyl]methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)C(F)(F)F)=C1 PFMPCBMZQGVWNK-UHFFFAOYSA-N 0.000 description 1
- KZVZNIJZRCPYPJ-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[[3-(trifluoromethyl)phenyl]methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=C(C=CC=2)C(F)(F)F)=C1 KZVZNIJZRCPYPJ-UHFFFAOYSA-N 0.000 description 1
- SAQPLBRUFYEYBH-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[[4-(trifluoromethoxy)phenyl]methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(OC(F)(F)F)=CC=2)=C1 SAQPLBRUFYEYBH-UHFFFAOYSA-N 0.000 description 1
- GRQSIFJZYNCJPF-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-phenyl-1-[[4-(trifluoromethyl)phenyl]methyl]imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)C(F)(F)F)=C1 GRQSIFJZYNCJPF-UHFFFAOYSA-N 0.000 description 1
- PWRXXLJTNHKURW-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-pyridin-3-yl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=NC=CC=2)=C1 PWRXXLJTNHKURW-UHFFFAOYSA-N 0.000 description 1
- LWXVOKVXRCTKPV-UHFFFAOYSA-N 2-(3-methylphenyl)-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound CC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 LWXVOKVXRCTKPV-UHFFFAOYSA-N 0.000 description 1
- NCTBRKOUFARGHB-UHFFFAOYSA-N 2-(3-methylphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 NCTBRKOUFARGHB-UHFFFAOYSA-N 0.000 description 1
- DLTMAXSFYQNOPR-UHFFFAOYSA-N 2-(3-methylsulfonylphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CS(=O)(=O)C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 DLTMAXSFYQNOPR-UHFFFAOYSA-N 0.000 description 1
- BDXQEYBQIQNLPJ-UHFFFAOYSA-N 2-(3-phenoxyphenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=CC=1OC1=CC=CC=C1 BDXQEYBQIQNLPJ-UHFFFAOYSA-N 0.000 description 1
- QELIBILUYBCDNX-UHFFFAOYSA-N 2-(3-phenoxyphenyl)-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC(C=2NC3=CC(=CN=C3N=2)C=2SC=CC=2)=CC=1OC1=CC=CC=C1 QELIBILUYBCDNX-UHFFFAOYSA-N 0.000 description 1
- NHGFXKLLIQHGJR-UHFFFAOYSA-N 2-(3-propan-2-yloxyphenyl)-6-[2-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 NHGFXKLLIQHGJR-UHFFFAOYSA-N 0.000 description 1
- TWDAJMZPYNDOAW-UHFFFAOYSA-N 2-(3-propan-2-yloxyphenyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(C=CC=2)C(F)(F)F)=C1 TWDAJMZPYNDOAW-UHFFFAOYSA-N 0.000 description 1
- KYNYNBFIQJHTDB-UHFFFAOYSA-N 2-(3-propan-2-yloxyphenyl)-6-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(OC(F)(F)F)=CC=2)=C1 KYNYNBFIQJHTDB-UHFFFAOYSA-N 0.000 description 1
- GXEUCWSRIKSINK-UHFFFAOYSA-N 2-(4-fluorophenyl)-6-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=CC(F)=CC=3)C2=C1 GXEUCWSRIKSINK-UHFFFAOYSA-N 0.000 description 1
- KRXNKYWUKHNZBX-UHFFFAOYSA-N 2-(4-fluorophenyl)-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=CC(F)=CC=2)=C1 KRXNKYWUKHNZBX-UHFFFAOYSA-N 0.000 description 1
- APIBSJFNWRABQI-UHFFFAOYSA-N 2-(4-fluorophenyl)-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 APIBSJFNWRABQI-UHFFFAOYSA-N 0.000 description 1
- HPEOXQRBAHYXIF-UHFFFAOYSA-N 2-(4-fluorophenyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 HPEOXQRBAHYXIF-UHFFFAOYSA-N 0.000 description 1
- MGKPFALCNDRSQD-UHFFFAOYSA-N 2-(4-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C=C1 MGKPFALCNDRSQD-UHFFFAOYSA-N 0.000 description 1
- IXBMJNDWTNCUFB-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C=CC(=CC=3)S(C)(=O)=O)C=C2N1 IXBMJNDWTNCUFB-UHFFFAOYSA-N 0.000 description 1
- MZYPCHCIVMZKQC-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)C(F)(F)F)C=C2O1 MZYPCHCIVMZKQC-UHFFFAOYSA-N 0.000 description 1
- OTGIKZQVZOCTAA-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C=C(C=CC=3)C(F)(F)F)C=C2N1 OTGIKZQVZOCTAA-UHFFFAOYSA-N 0.000 description 1
- WQCMCVCRNKVDQV-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 WQCMCVCRNKVDQV-UHFFFAOYSA-N 0.000 description 1
- CXJOONIFSVSFAD-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1 CXJOONIFSVSFAD-UHFFFAOYSA-N 0.000 description 1
- NNXRYGFDPXWKTA-UHFFFAOYSA-N 2-(5-methylthiophen-2-yl)-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound S1C(C)=CC=C1C1=NC2=NC=C(C=3C=C(C=CC=3)C(F)(F)F)C=C2N1 NNXRYGFDPXWKTA-UHFFFAOYSA-N 0.000 description 1
- BAWIDAJNAHBRIH-UHFFFAOYSA-N 2-(5-methylthiophen-2-yl)-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound S1C(C)=CC=C1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 BAWIDAJNAHBRIH-UHFFFAOYSA-N 0.000 description 1
- JJQFZRIPLVVYOD-UHFFFAOYSA-N 2-(5-methylthiophen-2-yl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound S1C(C)=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 JJQFZRIPLVVYOD-UHFFFAOYSA-N 0.000 description 1
- FCAJYRVEBULFKS-UHFFFAOYSA-N 2-(oxolan-2-yl)ethanol Chemical compound OCCC1CCCO1 FCAJYRVEBULFKS-UHFFFAOYSA-N 0.000 description 1
- YPHLCNDYLYPUNK-VAWYXSNFSA-N 2-(phenoxymethyl)-6-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(\C=C\C=3C=CC=CC=3)C=C2NC=1COC1=CC=CC=C1 YPHLCNDYLYPUNK-VAWYXSNFSA-N 0.000 description 1
- RXZBIODHMJVESX-UHFFFAOYSA-N 2-(phenoxymethyl)-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3C=CC=CC=3)C=C2NC=1COC1=CC=CC=C1 RXZBIODHMJVESX-UHFFFAOYSA-N 0.000 description 1
- VNODMTYMZKDPGU-UHFFFAOYSA-N 2-(phenoxymethyl)-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3SC=CC=3)C=C2NC=1COC1=CC=CC=C1 VNODMTYMZKDPGU-UHFFFAOYSA-N 0.000 description 1
- NCPFGXPKHFPYMO-UHFFFAOYSA-N 2-(phenylsulfanylmethyl)-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3SC=CC=3)C=C2NC=1CSC1=CC=CC=C1 NCPFGXPKHFPYMO-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HIGBGRWOJQQZKT-SFHVURJKSA-N 2-[(1s)-1-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)-2-phenylethyl]isoindole-1,3-dione Chemical compound C([C@@H](C1=NC2=NC=C(C=C2N1)Br)N1C(C2=CC=CC=C2C1=O)=O)C1=CC=CC=C1 HIGBGRWOJQQZKT-SFHVURJKSA-N 0.000 description 1
- QMRMRPIRFIFFNF-UHFFFAOYSA-N 2-[(2,4-difluorophenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC(F)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 QMRMRPIRFIFFNF-UHFFFAOYSA-N 0.000 description 1
- CDOSXZBDBJIGNF-UHFFFAOYSA-N 2-[(2,5-dimethoxyphenyl)methyl]-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=C(OC)C(CC=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 CDOSXZBDBJIGNF-UHFFFAOYSA-N 0.000 description 1
- XSGVTOSTUAAOMW-UHFFFAOYSA-N 2-[(2,5-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=C(OC)C(CC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 XSGVTOSTUAAOMW-UHFFFAOYSA-N 0.000 description 1
- BYCLICWLMMHNSX-UHFFFAOYSA-N 2-[(2,5-dimethoxyphenyl)methyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=C(OC)C(CC=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 BYCLICWLMMHNSX-UHFFFAOYSA-N 0.000 description 1
- NXEVSONVSJJPGX-UHFFFAOYSA-N 2-[(2,5-dimethoxyphenyl)methyl]-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=C(OC)C(CC=2NC3=CC(=CN=C3N=2)C=2SC=CC=2)=C1 NXEVSONVSJJPGX-UHFFFAOYSA-N 0.000 description 1
- HTQQWJIDCQTQQC-UHFFFAOYSA-N 2-[(2-chlorophenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 HTQQWJIDCQTQQC-UHFFFAOYSA-N 0.000 description 1
- PFLCFKZQVLVQEN-UHFFFAOYSA-N 2-[(3,4-dichlorophenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 PFLCFKZQVLVQEN-UHFFFAOYSA-N 0.000 description 1
- BBLIYWLWUVQXAK-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 BBLIYWLWUVQXAK-UHFFFAOYSA-N 0.000 description 1
- HHKFUZQFAKLMAB-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1-(2-methylpropyl)imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CC(C)C HHKFUZQFAKLMAB-UHFFFAOYSA-N 0.000 description 1
- VXZNQHBUURXEJO-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1-(2-phenylethyl)imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CCC1=CC=CC=C1 VXZNQHBUURXEJO-UHFFFAOYSA-N 0.000 description 1
- NSECDCRUBFNYIE-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1-methylimidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1C NSECDCRUBFNYIE-UHFFFAOYSA-N 0.000 description 1
- YYZZDBMTLBNTBX-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1-pent-4-enylimidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CCCC=C YYZZDBMTLBNTBX-UHFFFAOYSA-N 0.000 description 1
- BITDFTOLZJGADH-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 BITDFTOLZJGADH-UHFFFAOYSA-N 0.000 description 1
- SDZARETUXWSLRP-CMDGGOBGSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC(NC1=C2)=NC1=NC=C2\C=C\C1=CC=CC=C1 SDZARETUXWSLRP-CMDGGOBGSA-N 0.000 description 1
- ADSWPNAQCGMRBZ-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 ADSWPNAQCGMRBZ-UHFFFAOYSA-N 0.000 description 1
- XZUPKBQAUNSYKS-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-pyridin-3-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3C=NC=CC=3)C=C2N1 XZUPKBQAUNSYKS-UHFFFAOYSA-N 0.000 description 1
- ARIHFPJPXPVZSU-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3SC=CC=3)C=C2N1 ARIHFPJPXPVZSU-UHFFFAOYSA-N 0.000 description 1
- USXJKLIIGKSLRF-UHFFFAOYSA-N 2-[(3-methoxyphenyl)methyl]-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CC=2NC3=CC(=CN=C3N=2)C=2SC=CC=2)=C1 USXJKLIIGKSLRF-UHFFFAOYSA-N 0.000 description 1
- INDVIPASKSZPNT-UHFFFAOYSA-N 2-[(4-chlorophenoxy)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1OCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 INDVIPASKSZPNT-UHFFFAOYSA-N 0.000 description 1
- BVTAFZMKUKUKCX-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(CC=2C=CC(Cl)=CC=2)N2)C2=C1 BVTAFZMKUKUKCX-UHFFFAOYSA-N 0.000 description 1
- ZJMMDDSFBWZQOO-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=CC=C(C=3OC=CC=3)C=C2O1 ZJMMDDSFBWZQOO-UHFFFAOYSA-N 0.000 description 1
- WKHHRXLGMRAYDT-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 WKHHRXLGMRAYDT-UHFFFAOYSA-N 0.000 description 1
- RDKZHODOIYZNFK-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-phenyl-1,3-benzoxazole Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=CC=C(C=3C=CC=CC=3)C=C2O1 RDKZHODOIYZNFK-UHFFFAOYSA-N 0.000 description 1
- PFOFXDJUEHYFQD-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 PFOFXDJUEHYFQD-UHFFFAOYSA-N 0.000 description 1
- CQDNITADFZFPRO-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=NC=C(C=3SC=CC=3)C=C2N1 CQDNITADFZFPRO-UHFFFAOYSA-N 0.000 description 1
- HSWAOYVBZJIASG-UHFFFAOYSA-N 2-[(4-fluorophenyl)methyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 HSWAOYVBZJIASG-UHFFFAOYSA-N 0.000 description 1
- WPNNGPJJCLVZRP-UHFFFAOYSA-N 2-[(4-methoxy-3-methylphenyl)methyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(C)C(OC)=CC=C1CC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 WPNNGPJJCLVZRP-UHFFFAOYSA-N 0.000 description 1
- YZFTZZZTXCZPRD-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C=CC(=CC=3)S(C)(=O)=O)C=C2N1 YZFTZZZTXCZPRD-UHFFFAOYSA-N 0.000 description 1
- UGSDJKGWIJNLLG-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C=C(C=CC=3)C(F)(F)F)C=C2N1 UGSDJKGWIJNLLG-UHFFFAOYSA-N 0.000 description 1
- UQKOQBRUJQWXOS-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 UQKOQBRUJQWXOS-UHFFFAOYSA-N 0.000 description 1
- ZSOIXQVDJBLIAZ-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 ZSOIXQVDJBLIAZ-UHFFFAOYSA-N 0.000 description 1
- PICTZYLFXBHBQF-VMPITWQZSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-5-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 PICTZYLFXBHBQF-VMPITWQZSA-N 0.000 description 1
- CFPCKYVRBCGFFV-FCXQYMQBSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-5-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC(\C=C\C=3C=CC=CC=3)=CC=C2O1 CFPCKYVRBCGFFV-FCXQYMQBSA-N 0.000 description 1
- RPHFVMGVCBXDGH-DHZHZOJOSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-5-phenyl-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC(C=3C=CC=CC=3)=CC=C2O1 RPHFVMGVCBXDGH-DHZHZOJOSA-N 0.000 description 1
- CVMVETGIUMLVIN-VMPITWQZSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-5-pyridin-3-yl-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC(C=3C=NC=CC=3)=CC=C2O1 CVMVETGIUMLVIN-VMPITWQZSA-N 0.000 description 1
- UJEVHYBOBDDDBV-VMPITWQZSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 UJEVHYBOBDDDBV-VMPITWQZSA-N 0.000 description 1
- MWOZRJJSMCAGRD-DHZHZOJOSA-N 2-[(e)-2-(2,4-difluorophenyl)ethenyl]-6-phenyl-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC=C(C=3C=CC=CC=3)C=C2O1 MWOZRJJSMCAGRD-DHZHZOJOSA-N 0.000 description 1
- DMYSHRSJENYTDW-CSKARUKUSA-N 2-[(e)-2-(2-fluorophenyl)ethenyl]-5-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 DMYSHRSJENYTDW-CSKARUKUSA-N 0.000 description 1
- FVFYASASRDEHKJ-ACCUITESSA-N 2-[(e)-2-(2-fluorophenyl)ethenyl]-5-phenyl-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC(C=3C=CC=CC=3)=CC=C2O1 FVFYASASRDEHKJ-ACCUITESSA-N 0.000 description 1
- GVFOUOJUGOTJNX-CSKARUKUSA-N 2-[(e)-2-(2-fluorophenyl)ethenyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 GVFOUOJUGOTJNX-CSKARUKUSA-N 0.000 description 1
- QRTLHNZOSDVIMH-ACCUITESSA-N 2-[(e)-2-(2-fluorophenyl)ethenyl]-6-phenyl-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC=C(C=3C=CC=CC=3)C=C2O1 QRTLHNZOSDVIMH-ACCUITESSA-N 0.000 description 1
- WCFQDBBRFREGIN-XBXARRHUSA-N 2-[(e)-2-(3,4-dichlorophenyl)ethenyl]-5-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=C(Cl)C(Cl)=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 WCFQDBBRFREGIN-XBXARRHUSA-N 0.000 description 1
- WBODVDRXXHVWSX-YRNVUSSQSA-N 2-[(e)-2-(3,4-dichlorophenyl)ethenyl]-5-phenyl-1,3-benzoxazole Chemical compound C1=C(Cl)C(Cl)=CC=C1\C=C\C1=NC2=CC(C=3C=CC=CC=3)=CC=C2O1 WBODVDRXXHVWSX-YRNVUSSQSA-N 0.000 description 1
- IWFMSRQKHSEFSH-RMKNXTFCSA-N 2-[(e)-2-(3-fluorophenyl)ethenyl]-5-(furan-2-yl)-1,3-benzoxazole Chemical compound FC1=CC=CC(\C=C\C=2OC3=CC=C(C=C3N=2)C=2OC=CC=2)=C1 IWFMSRQKHSEFSH-RMKNXTFCSA-N 0.000 description 1
- PRQFFCHBJXSSDP-FMIVXFBMSA-N 2-[(e)-2-(3-fluorophenyl)ethenyl]-5-phenyl-1,3-benzoxazole Chemical compound FC1=CC=CC(\C=C\C=2OC3=CC=C(C=C3N=2)C=2C=CC=CC=2)=C1 PRQFFCHBJXSSDP-FMIVXFBMSA-N 0.000 description 1
- BFYAAVXCPDGKPV-BJMVGYQFSA-N 2-[(e)-2-(4-chlorophenyl)ethenyl]-5-(furan-2-yl)-1,3-benzoxazole Chemical compound C1=CC(Cl)=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 BFYAAVXCPDGKPV-BJMVGYQFSA-N 0.000 description 1
- QDJKGINZYDZUAK-SDNWHVSQSA-N 2-[(e)-2-(4-methylphenyl)ethenyl]-5-phenyl-1,3-benzoxazole Chemical compound C1=CC(C)=CC=C1\C=C\C1=NC2=CC(C=3C=CC=CC=3)=CC=C2O1 QDJKGINZYDZUAK-SDNWHVSQSA-N 0.000 description 1
- LABIFJVARBRBKA-LFIBNONCSA-N 2-[(e)-2-phenylethenyl]-5-[4-[4-(triazol-1-yl)butyl]phenoxy]-1,3-benzoxazole Chemical compound C=1C=C(OC=2C=C3N=C(\C=C\C=4C=CC=CC=4)OC3=CC=2)C=CC=1CCCCN1C=CN=N1 LABIFJVARBRBKA-LFIBNONCSA-N 0.000 description 1
- BXGMBOMUJDXZOP-DHZHZOJOSA-N 2-[(e)-2-phenylethenyl]-5-pyridin-3-yl-1,3-benzoxazole Chemical compound N=1C2=CC(C=3C=NC=CC=3)=CC=C2OC=1/C=C/C1=CC=CC=C1 BXGMBOMUJDXZOP-DHZHZOJOSA-N 0.000 description 1
- UXLOYCLICTWLBS-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 UXLOYCLICTWLBS-UHFFFAOYSA-N 0.000 description 1
- RAVOFJJESPVKGE-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 RAVOFJJESPVKGE-UHFFFAOYSA-N 0.000 description 1
- CKBWHMQOJKUBIW-UHFFFAOYSA-N 2-[2-(2-methoxyethoxy)phenyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COCCOC1=CC=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 CKBWHMQOJKUBIW-UHFFFAOYSA-N 0.000 description 1
- KAOQBVGLQXLERH-UHFFFAOYSA-N 2-[2-(2-methoxyphenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 KAOQBVGLQXLERH-UHFFFAOYSA-N 0.000 description 1
- VZWJTTZQDSRNGZ-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 VZWJTTZQDSRNGZ-UHFFFAOYSA-N 0.000 description 1
- XWUNDFPVZUZTMB-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 XWUNDFPVZUZTMB-UHFFFAOYSA-N 0.000 description 1
- XSICKOZRWWYTSC-UHFFFAOYSA-N 2-[2-(3,4-dimethoxyphenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 XSICKOZRWWYTSC-UHFFFAOYSA-N 0.000 description 1
- XHDCOKONONUJKO-UHFFFAOYSA-N 2-[2-(3-chlorophenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(CCC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 XHDCOKONONUJKO-UHFFFAOYSA-N 0.000 description 1
- JJGKIUMZWMOJCV-UHFFFAOYSA-N 2-[2-(3-chlorophenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(CCC=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 JJGKIUMZWMOJCV-UHFFFAOYSA-N 0.000 description 1
- SYXAUFBYRUECCV-UHFFFAOYSA-N 2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]-1-phenylethanone Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(=O)C=2C=CC=CC=2)=C1 SYXAUFBYRUECCV-UHFFFAOYSA-N 0.000 description 1
- ATOSBSZHUAHWMG-UHFFFAOYSA-N 2-[2-(4-butoxyphenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCCCC)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 ATOSBSZHUAHWMG-UHFFFAOYSA-N 0.000 description 1
- KEKZRQVSPUQHSC-UHFFFAOYSA-N 2-[2-(4-butoxyphenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCCCC)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 KEKZRQVSPUQHSC-UHFFFAOYSA-N 0.000 description 1
- KFRXJHMKNBSOFJ-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 KFRXJHMKNBSOFJ-UHFFFAOYSA-N 0.000 description 1
- DRXNKUBFOQZYMN-UHFFFAOYSA-N 2-[2-(4-ethoxyphenyl)ethyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCC)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 DRXNKUBFOQZYMN-UHFFFAOYSA-N 0.000 description 1
- JCYGAVORTMCLAG-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 JCYGAVORTMCLAG-UHFFFAOYSA-N 0.000 description 1
- SOJHXBCRMQGZQR-UHFFFAOYSA-N 2-[2-(4-methylphenyl)ethyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 SOJHXBCRMQGZQR-UHFFFAOYSA-N 0.000 description 1
- RZFWBTXZEPATQR-UHFFFAOYSA-N 2-[2-(4-nitrophenyl)ethyl]-6-phenyl-1h-benzimidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCC1=NC2=CC(C=3C=CC=CC=3)=CC=C2N1 RZFWBTXZEPATQR-UHFFFAOYSA-N 0.000 description 1
- HWCOPXAIVQYKKB-UHFFFAOYSA-N 2-[2-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]phenoxy]ethyl acetate Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)OCCOC(C)=O)=C1 HWCOPXAIVQYKKB-UHFFFAOYSA-N 0.000 description 1
- LJDPCWMGLWZFDT-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C2=C1 LJDPCWMGLWZFDT-UHFFFAOYSA-N 0.000 description 1
- NCLRBUIZBRJPEW-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 NCLRBUIZBRJPEW-UHFFFAOYSA-N 0.000 description 1
- OHBLOIREBBCZNB-UHFFFAOYSA-N 2-[3,5-bis(trifluoromethyl)phenyl]-6-bromo-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 OHBLOIREBBCZNB-UHFFFAOYSA-N 0.000 description 1
- CSFGIEYXDNWPDD-UHFFFAOYSA-N 2-[3-(2,2-dimethylpropoxy)phenyl]-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)(C)COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 CSFGIEYXDNWPDD-UHFFFAOYSA-N 0.000 description 1
- QEDNXLUGQQPPIB-UHFFFAOYSA-N 2-[3-(2,2-dimethylpropoxy)phenyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)(C)COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 QEDNXLUGQQPPIB-UHFFFAOYSA-N 0.000 description 1
- NPCCUPPQDWBZTM-UHFFFAOYSA-N 2-[3-(2,2-dimethylpropoxy)phenyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)(C)COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 NPCCUPPQDWBZTM-UHFFFAOYSA-N 0.000 description 1
- WPOPWJDJQRFGIC-UHFFFAOYSA-N 2-[3-(2-methoxyethoxy)phenyl]-6-phenyl-1,3-benzoxazole Chemical compound COCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C=CC=CC=2)=C1 WPOPWJDJQRFGIC-UHFFFAOYSA-N 0.000 description 1
- BXZWJTPTJPDKCP-UHFFFAOYSA-N 2-[3-(3-methylbutoxy)phenyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 BXZWJTPTJPDKCP-UHFFFAOYSA-N 0.000 description 1
- LOZKRWVRAUEDSV-UHFFFAOYSA-N 2-[3-(6-bromo-1,3-benzoxazol-2-yl)phenoxy]-n-methylacetamide Chemical compound CNC(=O)COC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 LOZKRWVRAUEDSV-UHFFFAOYSA-N 0.000 description 1
- NYYCUWRNFHXCRV-UHFFFAOYSA-N 2-[3-(cyclohexylmethoxy)phenyl]-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OCC4CCCCC4)C=CC=3)C2=C1 NYYCUWRNFHXCRV-UHFFFAOYSA-N 0.000 description 1
- WMJSLUITDUPFJR-UHFFFAOYSA-N 2-[3-(cyclohexylmethoxy)phenyl]-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCCC1COC(C=1)=CC=CC=1C(NC1=C2)=NC1=NC=C2C1=CC=CO1 WMJSLUITDUPFJR-UHFFFAOYSA-N 0.000 description 1
- CVBMEIIGDRCQQO-UHFFFAOYSA-N 2-[3-(cyclohexylmethoxy)phenyl]-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCCC1COC(C=1)=CC=CC=1C(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 CVBMEIIGDRCQQO-UHFFFAOYSA-N 0.000 description 1
- NVMSOJJZOOTSER-UHFFFAOYSA-N 2-[3-(cyclopropylmethoxy)phenyl]-6-(2,4-difluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1C1=CC=C(N=C(O2)C=3C=C(OCC4CC4)C=CC=3)C2=C1 NVMSOJJZOOTSER-UHFFFAOYSA-N 0.000 description 1
- ORHUHBKNRCPFEI-UHFFFAOYSA-N 2-[3-(cyclopropylmethoxy)phenyl]-6-(2-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(OCC4CC4)C=CC=3)C2=C1 ORHUHBKNRCPFEI-UHFFFAOYSA-N 0.000 description 1
- ODYDYGMYJQTAIV-UHFFFAOYSA-N 2-[3-(cyclopropylmethoxy)phenyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound C1CC1COC(C=1)=CC=CC=1C(OC1=C2)=NC1=CC=C2C1=CC=CO1 ODYDYGMYJQTAIV-UHFFFAOYSA-N 0.000 description 1
- SWOCTSSAAOYOLZ-UHFFFAOYSA-N 2-[3-(trifluoromethoxy)phenyl]-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 SWOCTSSAAOYOLZ-UHFFFAOYSA-N 0.000 description 1
- PMGWLEDLUXMZNO-UHFFFAOYSA-N 2-[3-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]propyl]isoindole-1,3-dione Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCCN2C(C3=CC=CC=C3C2=O)=O)=C1 PMGWLEDLUXMZNO-UHFFFAOYSA-N 0.000 description 1
- CKOQWZDJNHUURZ-UHFFFAOYSA-N 2-[3-[6-(2,4-difluorophenyl)-1,3-benzoxazol-2-yl]phenoxy]-n-methylacetamide Chemical compound CNC(=O)COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC(F)=CC=2)F)=C1 CKOQWZDJNHUURZ-UHFFFAOYSA-N 0.000 description 1
- WICJIRRCVJLDDG-UHFFFAOYSA-N 2-[3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]phenoxy]-n-methylacetamide Chemical compound CNC(=O)COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 WICJIRRCVJLDDG-UHFFFAOYSA-N 0.000 description 1
- NQRRCSFZUDSSDH-UHFFFAOYSA-N 2-[3-fluoro-5-(trifluoromethyl)phenyl]-6-(furan-2-yl)-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC(F)=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 NQRRCSFZUDSSDH-UHFFFAOYSA-N 0.000 description 1
- WCFOYDNLQUDRNJ-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(C=3C=C(C=CC=3)C(F)(F)F)C=C2N1 WCFOYDNLQUDRNJ-UHFFFAOYSA-N 0.000 description 1
- GIEOSORXOJFTDL-UHFFFAOYSA-N 2-[[2-(3-butoxyphenyl)-6-(furan-2-yl)imidazo[4,5-b]pyridin-1-yl]methyl]phenol Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)CC=2C(=CC=CC=2)O)=C1 GIEOSORXOJFTDL-UHFFFAOYSA-N 0.000 description 1
- FGGNAIMMXCQMIK-UHFFFAOYSA-N 2-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]quinoline Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2N=C3C=CC=CC3=CC=2)=C1 FGGNAIMMXCQMIK-UHFFFAOYSA-N 0.000 description 1
- ATVZIQADANQPAS-UHFFFAOYSA-N 2-[[2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)imidazo[4,5-b]pyridin-1-yl]methyl]phenol Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CC1=CC=CC=C1O ATVZIQADANQPAS-UHFFFAOYSA-N 0.000 description 1
- TUCAPQJBQJPHKQ-UHFFFAOYSA-N 2-[[2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]acetyl]amino]acetic acid Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(=O)NCC(O)=O)=C1 TUCAPQJBQJPHKQ-UHFFFAOYSA-N 0.000 description 1
- YGZFYDFBHIDIBH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCC(CO)N(CCO)CCO YGZFYDFBHIDIBH-UHFFFAOYSA-N 0.000 description 1
- QCXJFISCRQIYID-IAEPZHFASA-N 2-amino-1-n-[(3s,6s,7r,10s,16s)-3-[(2s)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-9-n-[(3s,6s,7r,10s,16s)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propa Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N=C2C(C(=O)N[C@@H]3C(=O)N[C@H](C(N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]3C)=O)[C@@H](C)CC)=C(N)C(=O)C(C)=C2O2)C2=C(C)C=C1 QCXJFISCRQIYID-IAEPZHFASA-N 0.000 description 1
- JHRIPENGTGSNPJ-UHFFFAOYSA-N 2-amino-4-bromophenol Chemical compound NC1=CC(Br)=CC=C1O JHRIPENGTGSNPJ-UHFFFAOYSA-N 0.000 description 1
- DRQWUAAWZFIVTF-UHFFFAOYSA-N 2-amino-5-bromophenol Chemical compound NC1=CC=C(Br)C=C1O DRQWUAAWZFIVTF-UHFFFAOYSA-N 0.000 description 1
- DYHBVEQMSCUSKN-UHFFFAOYSA-N 2-aminoacetic acid;2-chloro-2-methylpropane Chemical compound CC(C)(C)Cl.NCC(O)=O DYHBVEQMSCUSKN-UHFFFAOYSA-N 0.000 description 1
- PSRKSQGVMKRFGG-UHFFFAOYSA-N 2-benzyl-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(CC=2C=CC=CC=2)N2)C2=C1 PSRKSQGVMKRFGG-UHFFFAOYSA-N 0.000 description 1
- RCCXHHQDCCDZKW-UHFFFAOYSA-N 2-benzyl-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 RCCXHHQDCCDZKW-UHFFFAOYSA-N 0.000 description 1
- YDXTWQDOSWIRTC-UHFFFAOYSA-N 2-benzyl-6-bromo-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CC1=CC=CC=C1 YDXTWQDOSWIRTC-UHFFFAOYSA-N 0.000 description 1
- YKXOKCLKZIEXBD-UHFFFAOYSA-N 2-benzyl-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 YKXOKCLKZIEXBD-UHFFFAOYSA-N 0.000 description 1
- VUYCTXXRIQUJIC-UHFFFAOYSA-N 2-benzyl-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CS1 VUYCTXXRIQUJIC-UHFFFAOYSA-N 0.000 description 1
- MNMPLQRQWHONOU-UHFFFAOYSA-N 2-cyclohexyl-6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C3CCCCC3)C2=C1 MNMPLQRQWHONOU-UHFFFAOYSA-N 0.000 description 1
- LPTPYHJQCRPQQG-UHFFFAOYSA-N 2-cyclohexyl-6-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C2CCCCC2)=C1 LPTPYHJQCRPQQG-UHFFFAOYSA-N 0.000 description 1
- RQKZXWIVYIGVEP-UHFFFAOYSA-N 2-cyclohexyl-6-(4-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(N2)C3CCCCC3)C2=C1 RQKZXWIVYIGVEP-UHFFFAOYSA-N 0.000 description 1
- GMKCGUDBJRFRKR-UHFFFAOYSA-N 2-cyclohexyl-6-(furan-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCCC1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 GMKCGUDBJRFRKR-UHFFFAOYSA-N 0.000 description 1
- IATMICOSCNNABG-UHFFFAOYSA-N 2-cyclohexyl-6-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C=C3NC(=NC3=NC=2)C2CCCCC2)=C1 IATMICOSCNNABG-UHFFFAOYSA-N 0.000 description 1
- YMLRYVUUCFGPLC-UHFFFAOYSA-N 2-cyclohexyl-6-naphthalen-1-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCCC1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 YMLRYVUUCFGPLC-UHFFFAOYSA-N 0.000 description 1
- UTLZIIFKZMFTLJ-UHFFFAOYSA-N 2-cyclohexyl-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCCC1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 UTLZIIFKZMFTLJ-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- IHMXVSZXHFTOFN-UHFFFAOYSA-N 2-ethyloxolane Chemical compound CCC1CCCO1 IHMXVSZXHFTOFN-UHFFFAOYSA-N 0.000 description 1
- WRFPVMFCRNYQNR-UHFFFAOYSA-N 2-hydroxyphenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1O WRFPVMFCRNYQNR-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- GIWUWGWJJMXJLN-UHFFFAOYSA-N 2-naphthalen-2-yl-6-phenyl-1,3-benzoxazole Chemical compound C1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C4C=CC=CC4=CC=3)C2=C1 GIWUWGWJJMXJLN-UHFFFAOYSA-N 0.000 description 1
- MLTZINFEZUSXNY-UHFFFAOYSA-N 2-naphthalen-2-yl-6-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C4C=CC=CC4=CC=3)C2=C1 MLTZINFEZUSXNY-UHFFFAOYSA-N 0.000 description 1
- KMTFQTBRRSMGRP-UHFFFAOYSA-N 2-naphthalen-2-yl-6-thiophen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CSC(C=2C=C3NC(=NC3=NC=2)C=2C=C3C=CC=CC3=CC=2)=C1 KMTFQTBRRSMGRP-UHFFFAOYSA-N 0.000 description 1
- KCYFBMGGALMOFO-UHFFFAOYSA-N 2-phenyl-6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=CC=CC=3)C2=C1 KCYFBMGGALMOFO-UHFFFAOYSA-N 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- HXBBRPUHXRTNIR-UHFFFAOYSA-N 3-(6-bromo-1,3-benzoxazol-2-yl)benzonitrile Chemical compound O1C2=CC(Br)=CC=C2N=C1C1=CC=CC(C#N)=C1 HXBBRPUHXRTNIR-UHFFFAOYSA-N 0.000 description 1
- GICKTEXWNIVHMI-UHFFFAOYSA-N 3-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 GICKTEXWNIVHMI-UHFFFAOYSA-N 0.000 description 1
- WDRWNQWMGBCMKN-UHFFFAOYSA-N 3-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)benzonitrile Chemical compound N1C2=CC(Br)=CN=C2N=C1C1=CC=CC(C#N)=C1 WDRWNQWMGBCMKN-UHFFFAOYSA-N 0.000 description 1
- XUJAZLWLPQKRNT-UHFFFAOYSA-N 3-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)benzonitrile Chemical compound N#CC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 XUJAZLWLPQKRNT-UHFFFAOYSA-N 0.000 description 1
- UZGLOGCJCWBBIV-UHFFFAOYSA-N 3-(chloromethyl)pyridin-1-ium;chloride Chemical compound Cl.ClCC1=CC=CN=C1 UZGLOGCJCWBBIV-UHFFFAOYSA-N 0.000 description 1
- AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- HYFDJRLHTCIDHU-UHFFFAOYSA-N 3-[2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(C=CC=2)C#N)=C1 HYFDJRLHTCIDHU-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- XYEQUDXYHQMAKD-UHFFFAOYSA-N 3-[6-(2-fluorophenyl)-1,3-benzoxazol-2-yl]benzonitrile Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(C=CC=3)C#N)C2=C1 XYEQUDXYHQMAKD-UHFFFAOYSA-N 0.000 description 1
- IILRPDNSSIOHNW-UHFFFAOYSA-N 3-[6-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridin-2-yl]benzonitrile Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(C=CC=3)C#N)C2=C1 IILRPDNSSIOHNW-UHFFFAOYSA-N 0.000 description 1
- XVHRMBMURZSXMY-UHFFFAOYSA-N 3-[6-(3-methoxyphenyl)-1,3-benzoxazol-2-yl]benzonitrile Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(C=CC=2)C#N)=C1 XVHRMBMURZSXMY-UHFFFAOYSA-N 0.000 description 1
- GYSGALAEEWJNGH-UHFFFAOYSA-N 3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]aniline Chemical compound NC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 GYSGALAEEWJNGH-UHFFFAOYSA-N 0.000 description 1
- RRIHTMMTTZROOX-UHFFFAOYSA-N 3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]benzonitrile Chemical compound N#CC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 RRIHTMMTTZROOX-UHFFFAOYSA-N 0.000 description 1
- MDGVZDYNVWQGAS-UHFFFAOYSA-N 3-[6-(furan-2-yl)-1h-imidazo[4,5-b]pyridin-2-yl]-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 MDGVZDYNVWQGAS-UHFFFAOYSA-N 0.000 description 1
- MEERWMOQZCLMLZ-UHFFFAOYSA-N 3-[6-[2-(trifluoromethyl)phenyl]-1,3-benzoxazol-2-yl]benzonitrile Chemical compound FC(F)(F)C1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(C=CC=3)C#N)C2=C1 MEERWMOQZCLMLZ-UHFFFAOYSA-N 0.000 description 1
- WUIABRMSWOKTOF-OYALTWQYSA-N 3-[[2-[2-[2-[[(2s,3r)-2-[[(2s,3s,4r)-4-[[(2s,3r)-2-[[6-amino-2-[(1s)-3-amino-1-[[(2s)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2r,3s,4s,5r,6r)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)ox Chemical compound OS([O-])(=O)=O.N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1NC=NC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C WUIABRMSWOKTOF-OYALTWQYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JXEICPOBKSQAIU-UHFFFAOYSA-N 3-bromo-1-[12-(3-bromopropanoyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5^{9}.2^{6}]hexadecan-3-yl]propan-1-one Chemical compound C1CN(C(=O)CCBr)CC[N+]21CC[N+]1(CCN(CC1)C(=O)CCBr)CC2 JXEICPOBKSQAIU-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- DTFQMPQJMDEWKJ-UHFFFAOYSA-N 3-ethoxybenzoic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1 DTFQMPQJMDEWKJ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- CFHOXNBMLNSWCN-UHFFFAOYSA-N 4-[2-(1,3-benzodioxol-5-yl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CN=C(N=C(N2)C=3C=C4OCOC4=CC=3)C2=C1 CFHOXNBMLNSWCN-UHFFFAOYSA-N 0.000 description 1
- WJEDNFVFHWYHLI-UHFFFAOYSA-N 4-[2-(2-cyclopentylethyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CN=C(N=C(CCC2CCCC2)N2)C2=C1 WJEDNFVFHWYHLI-UHFFFAOYSA-N 0.000 description 1
- FQMIHZUIBSCXRD-UHFFFAOYSA-N 4-[2-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C=CC(=CC=3)C#N)C=C2N1 FQMIHZUIBSCXRD-UHFFFAOYSA-N 0.000 description 1
- CXUUZKXIVWGWEC-UHFFFAOYSA-N 4-[2-(3-butoxyphenyl)-6-(furan-2-yl)imidazo[4,5-b]pyridin-1-yl]butanenitrile Chemical compound CCCCOC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2OC=CC=2)CCCC#N)=C1 CXUUZKXIVWGWEC-UHFFFAOYSA-N 0.000 description 1
- OGHJUGAQMLTERP-UHFFFAOYSA-N 4-[2-(3-chlorophenyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound ClC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(=CC=2)C#N)=C1 OGHJUGAQMLTERP-UHFFFAOYSA-N 0.000 description 1
- GYQMLBGUPSWNHV-UHFFFAOYSA-N 4-[2-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(=CC=2)C#N)=C1 GYQMLBGUPSWNHV-UHFFFAOYSA-N 0.000 description 1
- YNAYCDCQBAMOFP-UHFFFAOYSA-N 4-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]butanenitrile Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCCC#N)=C1 YNAYCDCQBAMOFP-UHFFFAOYSA-N 0.000 description 1
- LGDPUUYNNXKQGE-UHFFFAOYSA-N 4-[2-(4-methoxyphenyl)-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C=CC(=CC=3)C#N)C=C2N1 LGDPUUYNNXKQGE-UHFFFAOYSA-N 0.000 description 1
- KAMWMLREOVMMEZ-UHFFFAOYSA-N 4-[2-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)ethyl]benzonitrile Chemical compound N1C2=CC(Br)=CN=C2N=C1CCC1=CC=C(C#N)C=C1 KAMWMLREOVMMEZ-UHFFFAOYSA-N 0.000 description 1
- AVXXJIQIERJKBB-UHFFFAOYSA-N 4-[2-[(3,4-dimethoxyphenyl)methyl]-6-(furan-2-yl)imidazo[4,5-b]pyridin-1-yl]butanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1CCCC#N AVXXJIQIERJKBB-UHFFFAOYSA-N 0.000 description 1
- BAGUUTWKOXCUPH-UHFFFAOYSA-N 4-[2-[(4-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C=CC(=CC=3)C#N)C=C2N1 BAGUUTWKOXCUPH-UHFFFAOYSA-N 0.000 description 1
- BJXLWRAPQKEYMK-UHFFFAOYSA-N 4-[2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]acetyl]benzonitrile Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC(=O)C=2C=CC(=CC=2)C#N)=C1 BJXLWRAPQKEYMK-UHFFFAOYSA-N 0.000 description 1
- NXJJLIKFWJUUNR-UHFFFAOYSA-N 4-[2-[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]ethyl]morpholine Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CCN2CCOCC2)=C1 NXJJLIKFWJUUNR-UHFFFAOYSA-N 0.000 description 1
- JIRQVYZIYPBFEB-UHFFFAOYSA-N 4-[2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridin-6-yl]benzonitrile Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(C=3C=CC(=CC=3)C#N)C=C2N1 JIRQVYZIYPBFEB-UHFFFAOYSA-N 0.000 description 1
- QXHOQSVMNJGFJK-UHFFFAOYSA-N 4-[2-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]phenoxy]butanoic acid Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)OCCCC(O)=O)=C1 QXHOQSVMNJGFJK-UHFFFAOYSA-N 0.000 description 1
- SVVYUVDFCBETIC-UHFFFAOYSA-N 4-[3-(6-bromo-1,3-benzoxazol-2-yl)phenoxy]butanenitrile Chemical compound O1C2=CC(Br)=CC=C2N=C1C1=CC=CC(OCCCC#N)=C1 SVVYUVDFCBETIC-UHFFFAOYSA-N 0.000 description 1
- MNDZNZMCMFMAML-UHFFFAOYSA-N 4-[3-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]morpholine Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=1)=CC=CC=1N1CCOCC1 MNDZNZMCMFMAML-UHFFFAOYSA-N 0.000 description 1
- PYDSYUYMHAHWJE-UHFFFAOYSA-N 4-[3-(6-phenyl-1,3-benzoxazol-2-yl)phenoxy]butanenitrile Chemical compound N#CCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C=CC=CC=2)=C1 PYDSYUYMHAHWJE-UHFFFAOYSA-N 0.000 description 1
- IRWKXYSPAATYGP-UHFFFAOYSA-N 4-[3-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]morpholine Chemical compound C1COCCN1C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 IRWKXYSPAATYGP-UHFFFAOYSA-N 0.000 description 1
- SCIZKYLCKRYHFG-UHFFFAOYSA-N 4-[3-[6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridin-2-yl]phenyl]morpholine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(C=CC=3)N3CCOCC3)C2=C1 SCIZKYLCKRYHFG-UHFFFAOYSA-N 0.000 description 1
- PBAXPUGVMRNPLC-UHFFFAOYSA-N 4-[3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]phenoxy]butanenitrile Chemical compound N#CCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 PBAXPUGVMRNPLC-UHFFFAOYSA-N 0.000 description 1
- GCBDUNIFOFISSK-UHFFFAOYSA-N 4-[3-[6-(furan-2-yl)-1h-imidazo[4,5-b]pyridin-2-yl]phenyl]morpholine Chemical compound C1COCCN1C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 GCBDUNIFOFISSK-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- ZHSKUOZOLHMKEA-UHFFFAOYSA-N 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydron;chloride Chemical compound Cl.ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 ZHSKUOZOLHMKEA-UHFFFAOYSA-N 0.000 description 1
- ABDZOVKENQRGRW-UHFFFAOYSA-N 4-[6-(furan-2-yl)-1h-imidazo[4,5-b]pyridin-2-yl]-5-methyl-3-phenyl-1,2-oxazole Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C(NC1=C2)=NC1=NC=C2C1=CC=CO1 ABDZOVKENQRGRW-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- QTIZBXDXDKGQEC-UHFFFAOYSA-N 4-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]-3,5-dimethyl-1,2-oxazole Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC2=C(ON=C2C)C)=C1 QTIZBXDXDKGQEC-UHFFFAOYSA-N 0.000 description 1
- WCVFOURTBKVZCQ-UHFFFAOYSA-N 4-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)C#N)=C1 WCVFOURTBKVZCQ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
- CDPKJZJVTHSESZ-UHFFFAOYSA-N 4-chlorophenylacetic acid Chemical compound OC(=O)CC1=CC=C(Cl)C=C1 CDPKJZJVTHSESZ-UHFFFAOYSA-N 0.000 description 1
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000006618 5- to 10-membered aromatic heterocyclic group Chemical group 0.000 description 1
- BVMCEEQZZXNCQF-NTEUORMPSA-N 5-(4-methylphenoxy)-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound C1=CC(C)=CC=C1OC1=CC=C(OC(\C=C\C=2C=CC=CC=2)=N2)C2=C1 BVMCEEQZZXNCQF-NTEUORMPSA-N 0.000 description 1
- XAHTZZMVSLMXJG-UHFFFAOYSA-N 5-(furan-2-yl)-2-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC=C(C=C3N=2)C=2OC=CC=2)=C1 XAHTZZMVSLMXJG-UHFFFAOYSA-N 0.000 description 1
- XSNKNGWFHVNMLT-DHZHZOJOSA-N 5-(furan-2-yl)-2-[(e)-2-(4-methylphenyl)ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C)=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 XSNKNGWFHVNMLT-DHZHZOJOSA-N 0.000 description 1
- RUASZPADVNYTSS-RMKNXTFCSA-N 5-(furan-2-yl)-2-[(e)-2-[3-(trifluoromethoxy)phenyl]ethenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(\C=C\C=2OC3=CC=C(C=C3N=2)C=2OC=CC=2)=C1 RUASZPADVNYTSS-RMKNXTFCSA-N 0.000 description 1
- RREUUULAQJPJCI-BJMVGYQFSA-N 5-(furan-2-yl)-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC(C=3OC=CC=3)=CC=C2O1 RREUUULAQJPJCI-BJMVGYQFSA-N 0.000 description 1
- XHGHVVKDQFYHPW-DHZHZOJOSA-N 5-(furan-2-yl)-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC(C=3OC=CC=3)=CC=C2OC=1/C=C/C1=CC=CC=C1 XHGHVVKDQFYHPW-DHZHZOJOSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- JUHAGTOOUWPDIP-OVCLIPMQSA-N 5-[4-[4-(triazol-1-yl)butyl]phenoxy]-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC(OC=3C=CC(CCCCN4N=NC=C4)=CC=3)=CC=C2O1 JUHAGTOOUWPDIP-OVCLIPMQSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- YLXFGKIFWFGIMQ-UHFFFAOYSA-N 5-bromo-2-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC=C(Br)C=C3N=2)=C1 YLXFGKIFWFGIMQ-UHFFFAOYSA-N 0.000 description 1
- ODNHEMFUXUSQJJ-QHHAFSJGSA-N 5-bromo-2-[(e)-2-(2,4-difluorophenyl)ethenyl]-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC(Br)=CC=C2O1 ODNHEMFUXUSQJJ-QHHAFSJGSA-N 0.000 description 1
- NKZYXTGQUUERTG-VMPITWQZSA-N 5-bromo-2-[(e)-2-(2-fluorophenyl)ethenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC(Br)=CC=C2O1 NKZYXTGQUUERTG-VMPITWQZSA-N 0.000 description 1
- AAGZHNNJUNFFMJ-QHHAFSJGSA-N 5-bromo-2-[(e)-2-(3,4-dichlorophenyl)ethenyl]-1,3-benzoxazole Chemical compound C1=C(Cl)C(Cl)=CC=C1\C=C\C1=NC2=CC(Br)=CC=C2O1 AAGZHNNJUNFFMJ-QHHAFSJGSA-N 0.000 description 1
- WAEOJZYFVXVPOF-QPJJXVBHSA-N 5-bromo-2-[(e)-2-(3-fluorophenyl)ethenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC(\C=C\C=2OC3=CC=C(Br)C=C3N=2)=C1 WAEOJZYFVXVPOF-QPJJXVBHSA-N 0.000 description 1
- YSMSKLYPKHIUKM-FPYGCLRLSA-N 5-bromo-2-[(e)-2-(4-chlorophenyl)ethenyl]-1,3-benzoxazole Chemical compound C1=CC(Cl)=CC=C1\C=C\C1=NC2=CC(Br)=CC=C2O1 YSMSKLYPKHIUKM-FPYGCLRLSA-N 0.000 description 1
- QAYNMFLZIIFSKT-QPJJXVBHSA-N 5-bromo-2-[(e)-2-[3-(trifluoromethoxy)phenyl]ethenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(\C=C\C=2OC3=CC=C(Br)C=C3N=2)=C1 QAYNMFLZIIFSKT-QPJJXVBHSA-N 0.000 description 1
- QOOCOFOGYRQPPN-UHFFFAOYSA-N 5-bromo-3-nitropyridin-2-amine Chemical compound NC1=NC=C(Br)C=C1[N+]([O-])=O QOOCOFOGYRQPPN-UHFFFAOYSA-N 0.000 description 1
- AIJBTVUVEYIEIX-FMIVXFBMSA-N 5-phenyl-2-[(e)-2-[3-(trifluoromethoxy)phenyl]ethenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(\C=C\C=2OC3=CC=C(C=C3N=2)C=2C=CC=CC=2)=C1 AIJBTVUVEYIEIX-FMIVXFBMSA-N 0.000 description 1
- FOFDUOMDOUWBAI-SDNWHVSQSA-N 5-phenyl-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC(C=3C=CC=CC=3)=CC=C2OC=1/C=C/C1=CC=CC=C1 FOFDUOMDOUWBAI-SDNWHVSQSA-N 0.000 description 1
- OHIUIUGALPVZPX-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-yl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C3OCOC3=CC=2)=C1 OHIUIUGALPVZPX-UHFFFAOYSA-N 0.000 description 1
- UPYYONZEMUAYMD-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC3=CC=CC=C3C=2)=C1 UPYYONZEMUAYMD-UHFFFAOYSA-N 0.000 description 1
- UEJZZNMHLLLXAX-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-(naphthalen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC2=CC(CC=3NC4=CC(=CN=C4N=3)C=3OC4=CC=CC=C4C=3)=CC=C21 UEJZZNMHLLLXAX-UHFFFAOYSA-N 0.000 description 1
- RITNLGKPQIYGNH-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-(thiophen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2NC=1CC1=CC=CS1 RITNLGKPQIYGNH-UHFFFAOYSA-N 0.000 description 1
- NQOWNXRSBMGXKE-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(1-methylindol-3-yl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C12=CC=CC=C2N(C)C=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 NQOWNXRSBMGXKE-UHFFFAOYSA-N 0.000 description 1
- VVRHOFIZMPPDOB-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(3,4,5-trimethoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CC=2NC3=CC(=CN=C3N=2)C=2OC3=CC=CC=C3C=2)=C1 VVRHOFIZMPPDOB-UHFFFAOYSA-N 0.000 description 1
- TYXRIBOZQDHDKB-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(3,4-dichlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 TYXRIBOZQDHDKB-UHFFFAOYSA-N 0.000 description 1
- WERYWCLMLGTFRX-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(3-chlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(CC=2NC3=CC(=CN=C3N=2)C=2OC3=CC=CC=C3C=2)=C1 WERYWCLMLGTFRX-UHFFFAOYSA-N 0.000 description 1
- HSUJCFANOFGGSD-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(4-chlorophenoxy)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1OCC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 HSUJCFANOFGGSD-UHFFFAOYSA-N 0.000 description 1
- MIUMBIMYTKCSJB-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(4-fluorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 MIUMBIMYTKCSJB-UHFFFAOYSA-N 0.000 description 1
- NLNDOHSXDHMLIK-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(4-methylsulfanylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(SC)=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 NLNDOHSXDHMLIK-UHFFFAOYSA-N 0.000 description 1
- KJUFPJMRNQXTPJ-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[(4-nitrophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 KJUFPJMRNQXTPJ-UHFFFAOYSA-N 0.000 description 1
- RYCNFYXLKDSCGL-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[2-(3,4-dimethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CCC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 RYCNFYXLKDSCGL-UHFFFAOYSA-N 0.000 description 1
- QMDQOWFLCQZJBE-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[[4-(trifluoromethoxy)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 QMDQOWFLCQZJBE-UHFFFAOYSA-N 0.000 description 1
- NJRYHXFGZZATMO-UHFFFAOYSA-N 6-(1-benzofuran-2-yl)-2-[[4-(trifluoromethyl)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CC1=NC2=NC=C(C=3OC4=CC=CC=C4C=3)C=C2N1 NJRYHXFGZZATMO-UHFFFAOYSA-N 0.000 description 1
- CALUJEUDSPUKJB-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-(2-methyl-3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC(F)=CC=2)F)=C1C CALUJEUDSPUKJB-UHFFFAOYSA-N 0.000 description 1
- IFRXDYXNVDGDLS-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-(3-hexoxyphenyl)-1,3-benzoxazole Chemical compound CCCCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC(F)=CC=2)F)=C1 IFRXDYXNVDGDLS-UHFFFAOYSA-N 0.000 description 1
- KDBBEHIWFCGLOC-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-(3-phenylmethoxyphenyl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1C1=CC=C(N=C(O2)C=3C=C(OCC=4C=CC=CC=4)C=CC=3)C2=C1 KDBBEHIWFCGLOC-UHFFFAOYSA-N 0.000 description 1
- ONGGVTGJZKNSQL-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-(3-propan-2-yloxyphenyl)-1,3-benzoxazole Chemical compound CC(C)OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC(F)=CC=2)F)=C1 ONGGVTGJZKNSQL-UHFFFAOYSA-N 0.000 description 1
- GDRSCFSVCVUIQK-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC(F)=CC=2)F)=C1 GDRSCFSVCVUIQK-UHFFFAOYSA-N 0.000 description 1
- YLLWOEFXLZVYPF-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-2-[3-(3-methylbutoxy)phenyl]-1,3-benzoxazole Chemical compound CC(C)CCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC(F)=CC=2)F)=C1 YLLWOEFXLZVYPF-UHFFFAOYSA-N 0.000 description 1
- JUODPLXROPZQKY-UHFFFAOYSA-N 6-(2-chlorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)Cl)=C1 JUODPLXROPZQKY-UHFFFAOYSA-N 0.000 description 1
- NUAWKBSZRJAVQW-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(2-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)F)C=C2O1 NUAWKBSZRJAVQW-UHFFFAOYSA-N 0.000 description 1
- TZTCTMHOLGXOFM-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 TZTCTMHOLGXOFM-UHFFFAOYSA-N 0.000 description 1
- XLTNPJHXHJABFI-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(2-methyl-3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1C XLTNPJHXHJABFI-UHFFFAOYSA-N 0.000 description 1
- CBPFWBZLUVBSOV-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(2-phenylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(CCC=2C=CC=CC=2)N2)C2=C1 CBPFWBZLUVBSOV-UHFFFAOYSA-N 0.000 description 1
- VLWLYCZGNDCSGS-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3,4,5-trimethoxyphenyl)-1,3-benzoxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 VLWLYCZGNDCSGS-UHFFFAOYSA-N 0.000 description 1
- HEHUXYQCZIIWII-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 HEHUXYQCZIIWII-UHFFFAOYSA-N 0.000 description 1
- ZCYNNJNCFUPOAR-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-hexoxyphenyl)-1,3-benzoxazole Chemical compound CCCCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 ZCYNNJNCFUPOAR-UHFFFAOYSA-N 0.000 description 1
- UIPZHILAVTWKJT-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 UIPZHILAVTWKJT-UHFFFAOYSA-N 0.000 description 1
- OSRIAMRKBYENBG-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-methylphenyl)-1,3-benzoxazole Chemical compound CC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 OSRIAMRKBYENBG-UHFFFAOYSA-N 0.000 description 1
- YCYJBUGOLRILSP-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-methylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 YCYJBUGOLRILSP-UHFFFAOYSA-N 0.000 description 1
- VLHPHXGLKUUKRT-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-nitrophenyl)-1,3-benzoxazole Chemical compound [O-][N+](=O)C1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 VLHPHXGLKUUKRT-UHFFFAOYSA-N 0.000 description 1
- BCCYVQZOALMVPY-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-phenoxyphenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(OC=4C=CC=CC=4)C=CC=3)C2=C1 BCCYVQZOALMVPY-UHFFFAOYSA-N 0.000 description 1
- WOJHECYJEYOIJR-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-phenoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OC=4C=CC=CC=4)C=CC=3)C2=C1 WOJHECYJEYOIJR-UHFFFAOYSA-N 0.000 description 1
- HHLAKKGXJNXQFE-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-phenylmethoxyphenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(OCC=4C=CC=CC=4)C=CC=3)C2=C1 HHLAKKGXJNXQFE-UHFFFAOYSA-N 0.000 description 1
- QYYXVSKEVNSLBR-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-propan-2-yloxyphenyl)-1,3-benzoxazole Chemical compound CC(C)OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 QYYXVSKEVNSLBR-UHFFFAOYSA-N 0.000 description 1
- RKPGBFBTLWBYSL-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 RKPGBFBTLWBYSL-UHFFFAOYSA-N 0.000 description 1
- MPGZDPNLDDXVOJ-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(3-propoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 MPGZDPNLDDXVOJ-UHFFFAOYSA-N 0.000 description 1
- YRCOFLBWRCNDFG-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(4-methoxyphenyl)-1,3-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)F)C=C2O1 YRCOFLBWRCNDFG-UHFFFAOYSA-N 0.000 description 1
- BIGHSDMJCUFNMC-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(4-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 BIGHSDMJCUFNMC-UHFFFAOYSA-N 0.000 description 1
- SJMLTFDNXMWHSR-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(5-methylthiophen-2-yl)-1,3-benzoxazole Chemical compound S1C(C)=CC=C1C1=NC2=CC=C(C=3C(=CC=CC=3)F)C=C2O1 SJMLTFDNXMWHSR-UHFFFAOYSA-N 0.000 description 1
- LKKLISAUMIUWGQ-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(5-methylthiophen-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound S1C(C)=CC=C1C1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 LKKLISAUMIUWGQ-UHFFFAOYSA-N 0.000 description 1
- JJWUPMIOLOCSDK-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(phenoxymethyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(COC=2C=CC=CC=2)N2)C2=C1 JJWUPMIOLOCSDK-UHFFFAOYSA-N 0.000 description 1
- ZVUZLJHIDMFSQK-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-(phenylsulfanylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(CSC=2C=CC=CC=2)N2)C2=C1 ZVUZLJHIDMFSQK-UHFFFAOYSA-N 0.000 description 1
- ZFONIRMAUHROSU-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[(4-methoxy-3-methylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(C)C(OC)=CC=C1CC1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 ZFONIRMAUHROSU-UHFFFAOYSA-N 0.000 description 1
- QVELNQFYKBSXEN-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[(4-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 QVELNQFYKBSXEN-UHFFFAOYSA-N 0.000 description 1
- UJFNDWAMSBFMDW-ZHACJKMWSA-N 6-(2-fluorophenyl)-2-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(\C=C\C=2C=CC=CC=2)N2)C2=C1 UJFNDWAMSBFMDW-ZHACJKMWSA-N 0.000 description 1
- XSEVZOCJTTZVOS-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[2-(4-propan-2-yloxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(C)C)=CC=C1CCC1=NC2=NC=C(C=3C(=CC=CC=3)F)C=C2N1 XSEVZOCJTTZVOS-UHFFFAOYSA-N 0.000 description 1
- FCJWEEMHQRZKCD-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(2,2,2-trifluoroethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OCC(F)(F)F)C=CC=3)C2=C1 FCJWEEMHQRZKCD-UHFFFAOYSA-N 0.000 description 1
- YJBRPLZXHOJMIE-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(2-methoxyethoxy)phenyl]-1,3-benzoxazole Chemical compound COCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 YJBRPLZXHOJMIE-UHFFFAOYSA-N 0.000 description 1
- XSCBUKSBBCWDOQ-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(3-methylbutoxy)phenyl]-1,3-benzoxazole Chemical compound CC(C)CCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 XSCBUKSBBCWDOQ-UHFFFAOYSA-N 0.000 description 1
- PNWBZTFZZJQUOG-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(3-methylbutoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C(=CC=CC=2)F)=C1 PNWBZTFZZJQUOG-UHFFFAOYSA-N 0.000 description 1
- PZYYBDOTJGJERH-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(trifluoromethoxy)phenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(OC(F)(F)F)C=CC=3)C2=C1 PZYYBDOTJGJERH-UHFFFAOYSA-N 0.000 description 1
- GTSVSTMDRJMZLD-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(C=CC=3)C(F)(F)F)C2=C1 GTSVSTMDRJMZLD-UHFFFAOYSA-N 0.000 description 1
- ANZQIEPGDIFFIP-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-(trifluoromethylsulfanyl)phenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C(SC(F)(F)F)C=CC=3)C2=C1 ANZQIEPGDIFFIP-UHFFFAOYSA-N 0.000 description 1
- YQKOSLPRNMGGQS-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[3-fluoro-5-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC(F)=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)F)=C1 YQKOSLPRNMGGQS-UHFFFAOYSA-N 0.000 description 1
- FTNHWJNDAUQUGS-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=CC(OC(F)(F)F)=CC=3)C2=C1 FTNHWJNDAUQUGS-UHFFFAOYSA-N 0.000 description 1
- ZHUUZKFMSXPMOG-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-naphthalen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C4C=CC=CC4=CC=3)C2=C1 ZHUUZKFMSXPMOG-UHFFFAOYSA-N 0.000 description 1
- GKCYFLFYUINONI-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-phenyl-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=CC=CC=3)C2=C1 GKCYFLFYUINONI-UHFFFAOYSA-N 0.000 description 1
- SBMFIJUEEFKFAS-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=CC=CC=3)C2=C1 SBMFIJUEEFKFAS-UHFFFAOYSA-N 0.000 description 1
- SZFQOBKBWSDSLA-UHFFFAOYSA-N 6-(2-fluorophenyl)-2-quinolin-6-yl-1,3-benzoxazole Chemical compound FC1=CC=CC=C1C1=CC=C(N=C(O2)C=3C=C4C=CC=NC4=CC=3)C2=C1 SZFQOBKBWSDSLA-UHFFFAOYSA-N 0.000 description 1
- UZOCORMEBPOMLF-UHFFFAOYSA-N 6-(2-methoxyphenyl)-2-(3-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(C=CC=3)S(C)(=O)=O)C2=C1 UZOCORMEBPOMLF-UHFFFAOYSA-N 0.000 description 1
- LSUJMHDHEXJVCB-UHFFFAOYSA-N 6-(2-methoxyphenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(OC(C)C)C=CC=3)C2=C1 LSUJMHDHEXJVCB-UHFFFAOYSA-N 0.000 description 1
- NBFWKLJSYFPNFN-UHFFFAOYSA-N 6-(2-methoxyphenyl)-2-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=C(C=CC=3)C(F)(F)F)C2=C1 NBFWKLJSYFPNFN-UHFFFAOYSA-N 0.000 description 1
- VEFCSHMRJVXSKZ-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(F)C(F)=CC=2)=C1 VEFCSHMRJVXSKZ-UHFFFAOYSA-N 0.000 description 1
- NYDMXFQJRDRKPW-UHFFFAOYSA-N 6-(3-fluorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(F)C=CC=2)=C1 NYDMXFQJRDRKPW-UHFFFAOYSA-N 0.000 description 1
- LGWFTHPHSNDVTG-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-(3-methylphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(C)C=CC=2)=C1 LGWFTHPHSNDVTG-UHFFFAOYSA-N 0.000 description 1
- QNCAFIOZYNDRQV-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=C(OC(C)C)C=CC=2)=C1 QNCAFIOZYNDRQV-UHFFFAOYSA-N 0.000 description 1
- RXNCNQPKRFNZBO-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-(4-methoxyphenyl)-1,3-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C=C(OC)C=CC=3)C=C2O1 RXNCNQPKRFNZBO-UHFFFAOYSA-N 0.000 description 1
- VFEYUYDEVBVSGA-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-(4-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(C=3C=C(OC)C=CC=3)C=C2N1 VFEYUYDEVBVSGA-UHFFFAOYSA-N 0.000 description 1
- LIOCLZRRPNZXII-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-[3-(trifluoromethoxy)phenyl]-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(OC(F)(F)F)C=CC=2)=C1 LIOCLZRRPNZXII-UHFFFAOYSA-N 0.000 description 1
- YUKNVCJLOIUNIO-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=C1 YUKNVCJLOIUNIO-UHFFFAOYSA-N 0.000 description 1
- WLORVZMEZNYPNJ-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=CC(OC(F)(F)F)=CC=2)=C1 WLORVZMEZNYPNJ-UHFFFAOYSA-N 0.000 description 1
- DGDSXPYUTSAXSS-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-phenyl-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2C=C3OC(=NC3=CC=2)C=2C=CC=CC=2)=C1 DGDSXPYUTSAXSS-UHFFFAOYSA-N 0.000 description 1
- NSSRRKQUKZDIEW-UHFFFAOYSA-N 6-(3-methoxyphenyl)-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2C=C3NC(=NC3=NC=2)C=2C=CC=CC=2)=C1 NSSRRKQUKZDIEW-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- UBOPNPLPXXSPMU-UHFFFAOYSA-N 6-(4-fluorophenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(F)=CC=2)=C1 UBOPNPLPXXSPMU-UHFFFAOYSA-N 0.000 description 1
- PVTLHNZEAZQBLX-UHFFFAOYSA-N 6-(4-methylsulfanylphenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(SC)=CC=C1C1=CN=C(N=C(N2)C=3C=C(OC(C)C)C=CC=3)C2=C1 PVTLHNZEAZQBLX-UHFFFAOYSA-N 0.000 description 1
- GGTCBUSVFGNBOU-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(N2)C=3C=CC(OC(F)(F)F)=CC=3)C2=C1 GGTCBUSVFGNBOU-UHFFFAOYSA-N 0.000 description 1
- QBFMMCCUTWRBLG-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N=C(N2)C=3C=CC=CC=3)C2=C1 QBFMMCCUTWRBLG-UHFFFAOYSA-N 0.000 description 1
- WVXHQTYCMAYXCN-UHFFFAOYSA-N 6-(4-phenoxyphenyl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC(OC=3C=CC=CC=3)=CC=2)=C1 WVXHQTYCMAYXCN-UHFFFAOYSA-N 0.000 description 1
- AUTJKQDEFKMMIW-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC=C1C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 AUTJKQDEFKMMIW-UHFFFAOYSA-N 0.000 description 1
- ATRYZGPXQNHZNX-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 ATRYZGPXQNHZNX-UHFFFAOYSA-N 0.000 description 1
- WYFNFCWEEHFWFY-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-methyl-3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1C WYFNFCWEEHFWFY-UHFFFAOYSA-N 0.000 description 1
- PBZUROGREGUARH-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-phenylcyclopropyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1C(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)C1C1=CC=CC=C1 PBZUROGREGUARH-UHFFFAOYSA-N 0.000 description 1
- NNVSBDKKUMNXGT-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-phenylethyl)-1,3-benzoxazole Chemical compound N=1C2=CC=C(C=3OC=CC=3)C=C2OC=1CCC1=CC=CC=C1 NNVSBDKKUMNXGT-UHFFFAOYSA-N 0.000 description 1
- ZZFHGBAWBUYRGR-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-phenylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC=CC=3)C=C2NC=1CCC1=CC=CC=C1 ZZFHGBAWBUYRGR-UHFFFAOYSA-N 0.000 description 1
- AHLWUZLSMZELRV-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-phenylpropyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1C(C)CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 AHLWUZLSMZELRV-UHFFFAOYSA-N 0.000 description 1
- LZFLRZDUBPLLGO-UHFFFAOYSA-N 6-(furan-2-yl)-2-(2-thiophen-2-ylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC=CC=3)C=C2NC=1CCC1=CC=CS1 LZFLRZDUBPLLGO-UHFFFAOYSA-N 0.000 description 1
- CWGUPIHQLNJVEZ-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3,4,5-trimethoxyphenyl)-1,3-benzoxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 CWGUPIHQLNJVEZ-UHFFFAOYSA-N 0.000 description 1
- OZBMVRQZMSJJFB-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-hexoxyphenyl)-1,3-benzoxazole Chemical compound CCCCCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 OZBMVRQZMSJJFB-UHFFFAOYSA-N 0.000 description 1
- NYGANNIRJRMXAQ-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-hexoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCCCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 NYGANNIRJRMXAQ-UHFFFAOYSA-N 0.000 description 1
- IUGTXONCJNNOIY-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 IUGTXONCJNNOIY-UHFFFAOYSA-N 0.000 description 1
- JDVCVKDAZDWEFK-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-methylphenyl)-1,3-benzoxazole Chemical compound CC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 JDVCVKDAZDWEFK-UHFFFAOYSA-N 0.000 description 1
- COQZEEHISBLPGF-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-methylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 COQZEEHISBLPGF-UHFFFAOYSA-N 0.000 description 1
- HCLCZSSVNFISSK-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CS(=O)(=O)C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 HCLCZSSVNFISSK-UHFFFAOYSA-N 0.000 description 1
- IITWTDQEWJASTA-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-nitrophenyl)-1,3-benzoxazole Chemical compound [O-][N+](=O)C1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 IITWTDQEWJASTA-UHFFFAOYSA-N 0.000 description 1
- ADHHXBVGZXFSFV-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-phenoxyphenyl)-1,3-benzoxazole Chemical compound C=1C=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=CC=1OC1=CC=CC=C1 ADHHXBVGZXFSFV-UHFFFAOYSA-N 0.000 description 1
- OXRYPONZDYHGJI-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-phenoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=CC=1OC1=CC=CC=C1 OXRYPONZDYHGJI-UHFFFAOYSA-N 0.000 description 1
- XDSZRRUCWDMOMP-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-phenylmethoxyphenyl)-1,3-benzoxazole Chemical compound C=1C=CC=CC=1COC(C=1)=CC=CC=1C(OC1=C2)=NC1=CC=C2C1=CC=CO1 XDSZRRUCWDMOMP-UHFFFAOYSA-N 0.000 description 1
- FPKQGOVNMPJIEL-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-propan-2-yloxyphenyl)-1,3-benzoxazole Chemical compound CC(C)OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 FPKQGOVNMPJIEL-UHFFFAOYSA-N 0.000 description 1
- GUOAINRDJJKOPM-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 GUOAINRDJJKOPM-UHFFFAOYSA-N 0.000 description 1
- GBKPUTRRFPILLI-UHFFFAOYSA-N 6-(furan-2-yl)-2-(3-pyrrolidin-1-ylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1CCCN1C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 GBKPUTRRFPILLI-UHFFFAOYSA-N 0.000 description 1
- YNNMHRZOEXMUMI-UHFFFAOYSA-N 6-(furan-2-yl)-2-(4-methoxyphenyl)-1,3-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 YNNMHRZOEXMUMI-UHFFFAOYSA-N 0.000 description 1
- YTVNPCDUJXEDIH-UHFFFAOYSA-N 6-(furan-2-yl)-2-(5-methylthiophen-2-yl)-1,3-benzoxazole Chemical compound S1C(C)=CC=C1C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 YTVNPCDUJXEDIH-UHFFFAOYSA-N 0.000 description 1
- YPZNEHMMBNFZPT-UHFFFAOYSA-N 6-(furan-2-yl)-2-(5-methylthiophen-2-yl)-1h-imidazo[4,5-b]pyridine Chemical compound S1C(C)=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 YPZNEHMMBNFZPT-UHFFFAOYSA-N 0.000 description 1
- VYMIIXRDGLNFNL-UHFFFAOYSA-N 6-(furan-2-yl)-2-(5-phenylpentyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1CCCCCC(NC1=C2)=NC1=NC=C2C1=CC=CO1 VYMIIXRDGLNFNL-UHFFFAOYSA-N 0.000 description 1
- DURMBCIGAOBAOZ-UHFFFAOYSA-N 6-(furan-2-yl)-2-(naphthalen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=C2C=CC=CC2=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 DURMBCIGAOBAOZ-UHFFFAOYSA-N 0.000 description 1
- ULTIVOZZOOCJKK-UHFFFAOYSA-N 6-(furan-2-yl)-2-(phenoxymethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC=CC=3)C=C2NC=1COC1=CC=CC=C1 ULTIVOZZOOCJKK-UHFFFAOYSA-N 0.000 description 1
- GUAJMUFPERBVBL-UHFFFAOYSA-N 6-(furan-2-yl)-2-(phenylsulfanylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC=CC=3)C=C2NC=1CSC1=CC=CC=C1 GUAJMUFPERBVBL-UHFFFAOYSA-N 0.000 description 1
- VUJUFUOJECMFPE-UHFFFAOYSA-N 6-(furan-2-yl)-2-(thiophen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CSC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 VUJUFUOJECMFPE-UHFFFAOYSA-N 0.000 description 1
- YBGKSRBEVALTLU-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(1-methylindol-3-yl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C12=CC=CC=C2N(C)C=C1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 YBGKSRBEVALTLU-UHFFFAOYSA-N 0.000 description 1
- SQSUNUTWHRUNBZ-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(3,4,5-trimethoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 SQSUNUTWHRUNBZ-UHFFFAOYSA-N 0.000 description 1
- LXRXIPAGEJKZKF-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(3-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 LXRXIPAGEJKZKF-UHFFFAOYSA-N 0.000 description 1
- RAFMQBSPSCKRAO-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(4-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 RAFMQBSPSCKRAO-UHFFFAOYSA-N 0.000 description 1
- YAOAKKPHOMWRJJ-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(4-methylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 YAOAKKPHOMWRJJ-UHFFFAOYSA-N 0.000 description 1
- GUJAMFAHRXDKFV-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(4-methylsulfanylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(SC)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 GUJAMFAHRXDKFV-UHFFFAOYSA-N 0.000 description 1
- ZFHQBMFRGCGNIH-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(4-nitrophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 ZFHQBMFRGCGNIH-UHFFFAOYSA-N 0.000 description 1
- OZWHCRLQMDOXGC-UHFFFAOYSA-N 6-(furan-2-yl)-2-[(4-phenylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CC(NC1=C2)=NC1=NC=C2C1=CC=CO1 OZWHCRLQMDOXGC-UHFFFAOYSA-N 0.000 description 1
- SMJMVNJRUKBULZ-BJMVGYQFSA-N 6-(furan-2-yl)-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC=C(C=3OC=CC=3)C=C2O1 SMJMVNJRUKBULZ-BJMVGYQFSA-N 0.000 description 1
- XYGHHYLCSYLQIL-DHZHZOJOSA-N 6-(furan-2-yl)-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC=C(C=3OC=CC=3)C=C2OC=1/C=C/C1=CC=CC=C1 XYGHHYLCSYLQIL-DHZHZOJOSA-N 0.000 description 1
- HUKDNUHDWAVNRI-CMDGGOBGSA-N 6-(furan-2-yl)-2-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3OC=CC=3)C=C2NC=1/C=C/C1=CC=CC=C1 HUKDNUHDWAVNRI-CMDGGOBGSA-N 0.000 description 1
- GBILPKHZHAITHG-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(2-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 GBILPKHZHAITHG-UHFFFAOYSA-N 0.000 description 1
- OSMZWPVRSJNCHQ-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(3,4,5-trimethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CCC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 OSMZWPVRSJNCHQ-UHFFFAOYSA-N 0.000 description 1
- REVNVGJSUXNCEN-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(3-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CCC=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 REVNVGJSUXNCEN-UHFFFAOYSA-N 0.000 description 1
- XSSAVKXYZOJDJT-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(4-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 XSSAVKXYZOJDJT-UHFFFAOYSA-N 0.000 description 1
- TVHYZMXZHSNAJK-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(4-methylphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 TVHYZMXZHSNAJK-UHFFFAOYSA-N 0.000 description 1
- BKHZCDIZHHVFLD-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(4-propan-2-yloxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(C)C)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 BKHZCDIZHHVFLD-UHFFFAOYSA-N 0.000 description 1
- ZXWSAHJSBCRXBV-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-(4-propan-2-ylphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(C)C)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 ZXWSAHJSBCRXBV-UHFFFAOYSA-N 0.000 description 1
- AWFLMESUGIZUTR-UHFFFAOYSA-N 6-(furan-2-yl)-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CCC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 AWFLMESUGIZUTR-UHFFFAOYSA-N 0.000 description 1
- VRTIQKLGXNHPOH-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(2,2,2-trifluoroethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 VRTIQKLGXNHPOH-UHFFFAOYSA-N 0.000 description 1
- PDIFBPOQSSCMTP-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(2-methoxyethoxy)phenyl]-1,3-benzoxazole Chemical compound COCCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 PDIFBPOQSSCMTP-UHFFFAOYSA-N 0.000 description 1
- NIDYWQLHUGWYDD-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(2-methoxyethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COCCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 NIDYWQLHUGWYDD-UHFFFAOYSA-N 0.000 description 1
- QIDUGGXKFMATND-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(2-phenylethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=CC=1OCCC1=CC=CC=C1 QIDUGGXKFMATND-UHFFFAOYSA-N 0.000 description 1
- AJNKPPLBRKRYPN-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(3-methylbutoxy)phenyl]-1,3-benzoxazole Chemical compound CC(C)CCOC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 AJNKPPLBRKRYPN-UHFFFAOYSA-N 0.000 description 1
- STUOAJONDNUCMI-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(3-methylbutoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)CCOC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 STUOAJONDNUCMI-UHFFFAOYSA-N 0.000 description 1
- HGCADOSBYZZJAN-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(trifluoromethoxy)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 HGCADOSBYZZJAN-UHFFFAOYSA-N 0.000 description 1
- CUKNWLMCJVZELD-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 CUKNWLMCJVZELD-UHFFFAOYSA-N 0.000 description 1
- BWOXEGWPQQJGCT-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)=C1 BWOXEGWPQQJGCT-UHFFFAOYSA-N 0.000 description 1
- LOMLYVSCZZNUGI-UHFFFAOYSA-N 6-(furan-2-yl)-2-[3-(trifluoromethylsulfanyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)SC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 LOMLYVSCZZNUGI-UHFFFAOYSA-N 0.000 description 1
- GMHZRCLPYORGJP-UHFFFAOYSA-N 6-(furan-2-yl)-2-[4-(2-methoxyethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCCOC)=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 GMHZRCLPYORGJP-UHFFFAOYSA-N 0.000 description 1
- WCWXRKPSZBNUNP-UHFFFAOYSA-N 6-(furan-2-yl)-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(C=3OC=CC=3)C=C2N1 WCWXRKPSZBNUNP-UHFFFAOYSA-N 0.000 description 1
- ZAIMPORRWHPQAY-UHFFFAOYSA-N 6-(furan-2-yl)-2-[[4-(trifluoromethoxy)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 ZAIMPORRWHPQAY-UHFFFAOYSA-N 0.000 description 1
- NLUJHIRNHBTIPP-UHFFFAOYSA-N 6-(furan-2-yl)-2-[[4-(trifluoromethyl)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CC1=NC2=NC=C(C=3OC=CC=3)C=C2N1 NLUJHIRNHBTIPP-UHFFFAOYSA-N 0.000 description 1
- XJIHKTZDGRCLAA-UHFFFAOYSA-N 6-(furan-2-yl)-2-naphthalen-2-yl-1,3-benzoxazole Chemical compound C1=COC(C=2C=C3OC(=NC3=CC=2)C=2C=C3C=CC=CC3=CC=2)=C1 XJIHKTZDGRCLAA-UHFFFAOYSA-N 0.000 description 1
- VXCWFERWPRBKOP-UHFFFAOYSA-N 6-(furan-2-yl)-2-naphthalen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=COC(C=2C=C3NC(=NC3=NC=2)C=2C=C3C=CC=CC3=CC=2)=C1 VXCWFERWPRBKOP-UHFFFAOYSA-N 0.000 description 1
- RFEYJFDDERAIFA-UHFFFAOYSA-N 6-(furan-2-yl)-2-phenyl-1,3-benzoxazole Chemical compound C1=COC(C=2C=C3OC(=NC3=CC=2)C=2C=CC=CC=2)=C1 RFEYJFDDERAIFA-UHFFFAOYSA-N 0.000 description 1
- BPFRWUKXRVYCHE-UHFFFAOYSA-N 6-(furan-2-yl)-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=COC(C=2C=C3NC(=NC3=NC=2)C=2C=CC=CC=2)=C1 BPFRWUKXRVYCHE-UHFFFAOYSA-N 0.000 description 1
- NXOPGHSOXXUWHG-UHFFFAOYSA-N 6-(furan-2-yl)-2-quinolin-6-yl-1,3-benzoxazole Chemical compound C1=COC(C=2C=C3OC(=NC3=CC=2)C=2C=C3C=CC=NC3=CC=2)=C1 NXOPGHSOXXUWHG-UHFFFAOYSA-N 0.000 description 1
- TVTCJOIUGMJLOM-UHFFFAOYSA-N 6-(furan-3-yl)-2-(3-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C2=COC=C2)=C1 TVTCJOIUGMJLOM-UHFFFAOYSA-N 0.000 description 1
- WYWHKKSPHMUBEB-UHFFFAOYSA-N 6-Mercaptoguanine Natural products N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 1
- BJPWQCDRDCPUHG-UHFFFAOYSA-N 6-[2-(trifluoromethyl)phenyl]-2-(3,4,5-trimethoxyphenyl)-1,3-benzoxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 BJPWQCDRDCPUHG-UHFFFAOYSA-N 0.000 description 1
- NRLHFJALZLTHBH-UHFFFAOYSA-N 6-[2-(trifluoromethyl)phenyl]-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2C(=CC=CC=2)C(F)(F)F)=C1 NRLHFJALZLTHBH-UHFFFAOYSA-N 0.000 description 1
- RYKCYJNVUGMHQJ-UHFFFAOYSA-N 6-bromo-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-1h-imidazo[4,5-b]pyridine Chemical compound O1CCOC2=CC(C3=NC4=NC=C(C=C4N3)Br)=CC=C21 RYKCYJNVUGMHQJ-UHFFFAOYSA-N 0.000 description 1
- HJUJPUGJRRSVBR-UHFFFAOYSA-N 6-bromo-2-(2-cyclopentylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CCC1CCCC1 HJUJPUGJRRSVBR-UHFFFAOYSA-N 0.000 description 1
- JOPZJHHRXKTFGW-UHFFFAOYSA-N 6-bromo-2-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC=C1C1=NC2=NC=C(Br)C=C2N1 JOPZJHHRXKTFGW-UHFFFAOYSA-N 0.000 description 1
- VZDOVQCNJLZLAP-UHFFFAOYSA-N 6-bromo-2-(2-methoxyphenyl)-1,3-benzoxazole Chemical compound COC1=CC=CC=C1C1=NC2=CC=C(Br)C=C2O1 VZDOVQCNJLZLAP-UHFFFAOYSA-N 0.000 description 1
- WEROVQQJYQFKPJ-UHFFFAOYSA-N 6-bromo-2-(2-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1C1=NC2=NC=C(Br)C=C2N1 WEROVQQJYQFKPJ-UHFFFAOYSA-N 0.000 description 1
- LMKZZJTXEIXFKB-UHFFFAOYSA-N 6-bromo-2-(2-methyl-3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1C LMKZZJTXEIXFKB-UHFFFAOYSA-N 0.000 description 1
- ZMDZTRJAZDSUTC-UHFFFAOYSA-N 6-bromo-2-(2-phenylcyclopropyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C1CC1C1=CC=CC=C1 ZMDZTRJAZDSUTC-UHFFFAOYSA-N 0.000 description 1
- CDBWCAPGTPSQKS-UHFFFAOYSA-N 6-bromo-2-(2-phenylethyl)-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1CCC1=CC=CC=C1 CDBWCAPGTPSQKS-UHFFFAOYSA-N 0.000 description 1
- GBISGYUUEXWSPK-UHFFFAOYSA-N 6-bromo-2-(2-phenylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CCC1=CC=CC=C1 GBISGYUUEXWSPK-UHFFFAOYSA-N 0.000 description 1
- DRXDJKCBXYQGKT-UHFFFAOYSA-N 6-bromo-2-(2-phenylpropyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(Br)C=C2NC=1CC(C)C1=CC=CC=C1 DRXDJKCBXYQGKT-UHFFFAOYSA-N 0.000 description 1
- BMXRNWSCMNRSGE-UHFFFAOYSA-N 6-bromo-2-(2-thiophen-2-ylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CCC1=CC=CS1 BMXRNWSCMNRSGE-UHFFFAOYSA-N 0.000 description 1
- MIKUZYZHYUYLBY-UHFFFAOYSA-N 6-bromo-2-(3,4,5-trimethoxyphenyl)-1,3-benzoxazole Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 MIKUZYZHYUYLBY-UHFFFAOYSA-N 0.000 description 1
- WGARONVJAODWCP-UHFFFAOYSA-N 6-bromo-2-(3,4-dimethoxyphenyl)-1,3-benzoxazole Chemical compound C1=C(OC)C(OC)=CC=C1C1=NC2=CC=C(Br)C=C2O1 WGARONVJAODWCP-UHFFFAOYSA-N 0.000 description 1
- DOJZHEHZWAALSR-UHFFFAOYSA-N 6-bromo-2-(3,5-difluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC(F)=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 DOJZHEHZWAALSR-UHFFFAOYSA-N 0.000 description 1
- LHFXPGCRDAAPFE-UHFFFAOYSA-N 6-bromo-2-(3-but-3-enoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C1=CC=CC(OCCC=C)=C1 LHFXPGCRDAAPFE-UHFFFAOYSA-N 0.000 description 1
- UNAOOIVXMIIZAI-UHFFFAOYSA-N 6-bromo-2-(3-butoxyphenyl)-1,3-benzoxazole Chemical compound CCCCOC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 UNAOOIVXMIIZAI-UHFFFAOYSA-N 0.000 description 1
- WVYAEMAQUQZUDC-UHFFFAOYSA-N 6-bromo-2-(3-chlorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 WVYAEMAQUQZUDC-UHFFFAOYSA-N 0.000 description 1
- KYXPBLUIEODHCE-UHFFFAOYSA-N 6-bromo-2-(3-cyclopentyloxyphenyl)-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1OC1CCCC1 KYXPBLUIEODHCE-UHFFFAOYSA-N 0.000 description 1
- IIBOUKPFVWMRNJ-UHFFFAOYSA-N 6-bromo-2-(3-cyclopentyloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=1)=CC=CC=1OC1CCCC1 IIBOUKPFVWMRNJ-UHFFFAOYSA-N 0.000 description 1
- WNBUILKSORMEOW-UHFFFAOYSA-N 6-bromo-2-(3-ethoxyphenyl)-1,3-benzoxazole Chemical compound CCOC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 WNBUILKSORMEOW-UHFFFAOYSA-N 0.000 description 1
- BDOCOBLDNXZCGA-UHFFFAOYSA-N 6-bromo-2-(3-ethoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCOC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 BDOCOBLDNXZCGA-UHFFFAOYSA-N 0.000 description 1
- IWOSSMXAUZFVAH-UHFFFAOYSA-N 6-bromo-2-(3-ethylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 IWOSSMXAUZFVAH-UHFFFAOYSA-N 0.000 description 1
- YEZDLLCCCHCBDJ-UHFFFAOYSA-N 6-bromo-2-(3-fluoro-4-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(F)C(OC)=CC=C1C1=NC2=NC=C(Br)C=C2N1 YEZDLLCCCHCBDJ-UHFFFAOYSA-N 0.000 description 1
- KNLTYZMRWIEZET-UHFFFAOYSA-N 6-bromo-2-(3-fluorophenyl)-1,3-benzoxazole Chemical compound FC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 KNLTYZMRWIEZET-UHFFFAOYSA-N 0.000 description 1
- HVPMJNJOKCYHAL-UHFFFAOYSA-N 6-bromo-2-(3-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 HVPMJNJOKCYHAL-UHFFFAOYSA-N 0.000 description 1
- DZOKWSOPVQXWMQ-UHFFFAOYSA-N 6-bromo-2-(3-hexoxyphenyl)-1,3-benzoxazole Chemical compound CCCCCCOC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 DZOKWSOPVQXWMQ-UHFFFAOYSA-N 0.000 description 1
- WOUFRYLGXLGZRO-UHFFFAOYSA-N 6-bromo-2-(3-hexoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCCCCOC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 WOUFRYLGXLGZRO-UHFFFAOYSA-N 0.000 description 1
- BQKLZLVRSPXDGF-UHFFFAOYSA-N 6-bromo-2-(3-methylphenyl)-1,3-benzoxazole Chemical compound CC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 BQKLZLVRSPXDGF-UHFFFAOYSA-N 0.000 description 1
- XPMTZEJBGPRKDD-UHFFFAOYSA-N 6-bromo-2-(3-methylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 XPMTZEJBGPRKDD-UHFFFAOYSA-N 0.000 description 1
- DUASKEJWYRQPGP-UHFFFAOYSA-N 6-bromo-2-(3-methylsulfonylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CS(=O)(=O)C1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 DUASKEJWYRQPGP-UHFFFAOYSA-N 0.000 description 1
- FQVJTOAITFNQIX-UHFFFAOYSA-N 6-bromo-2-(3-phenoxyphenyl)-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1OC1=CC=CC=C1 FQVJTOAITFNQIX-UHFFFAOYSA-N 0.000 description 1
- JDQSLQHPEDQLEI-UHFFFAOYSA-N 6-bromo-2-(3-phenylmethoxyphenyl)-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1OCC1=CC=CC=C1 JDQSLQHPEDQLEI-UHFFFAOYSA-N 0.000 description 1
- ICZMJHTXUKAAKX-UHFFFAOYSA-N 6-bromo-2-(3-propan-2-yloxyphenyl)-1,3-benzoxazole Chemical compound CC(C)OC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 ICZMJHTXUKAAKX-UHFFFAOYSA-N 0.000 description 1
- FPYWELSBZSQLPH-UHFFFAOYSA-N 6-bromo-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 FPYWELSBZSQLPH-UHFFFAOYSA-N 0.000 description 1
- WPNDEFPDANWFIJ-UHFFFAOYSA-N 6-bromo-2-(3-propoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CCCOC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 WPNDEFPDANWFIJ-UHFFFAOYSA-N 0.000 description 1
- RFMMWCSKJUYBAB-UHFFFAOYSA-N 6-bromo-2-(3-pyrrolidin-1-ylphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=1)=CC=CC=1N1CCCC1 RFMMWCSKJUYBAB-UHFFFAOYSA-N 0.000 description 1
- MIKMIYJKROMGTM-UHFFFAOYSA-N 6-bromo-2-(4-fluorophenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1C1=NC2=NC=C(Br)C=C2N1 MIKMIYJKROMGTM-UHFFFAOYSA-N 0.000 description 1
- OADOPEZKTQAGOD-UHFFFAOYSA-N 6-bromo-2-(4-methoxyphenyl)-1,3-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(Br)C=C2O1 OADOPEZKTQAGOD-UHFFFAOYSA-N 0.000 description 1
- KXXNSRRQEABRTD-UHFFFAOYSA-N 6-bromo-2-(4-methoxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1C1=NC2=NC=C(Br)C=C2N1 KXXNSRRQEABRTD-UHFFFAOYSA-N 0.000 description 1
- WXXUBKWFKKICNR-UHFFFAOYSA-N 6-bromo-2-(5-methylthiophen-2-yl)-1,3-benzoxazole Chemical compound S1C(C)=CC=C1C1=NC2=CC=C(Br)C=C2O1 WXXUBKWFKKICNR-UHFFFAOYSA-N 0.000 description 1
- BWHSRLMWECLHMC-UHFFFAOYSA-N 6-bromo-2-(5-phenylpentyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CCCCCC1=CC=CC=C1 BWHSRLMWECLHMC-UHFFFAOYSA-N 0.000 description 1
- LYOOYOFBJDAAHP-UHFFFAOYSA-N 6-bromo-2-(naphthalen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC2=CC(CC3=NC4=NC=C(C=C4N3)Br)=CC=C21 LYOOYOFBJDAAHP-UHFFFAOYSA-N 0.000 description 1
- GVSFRLHWAWMXNM-UHFFFAOYSA-N 6-bromo-2-(phenoxymethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1COC1=CC=CC=C1 GVSFRLHWAWMXNM-UHFFFAOYSA-N 0.000 description 1
- ZGDCGVCVCBWUHA-UHFFFAOYSA-N 6-bromo-2-(phenylsulfanylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CSC1=CC=CC=C1 ZGDCGVCVCBWUHA-UHFFFAOYSA-N 0.000 description 1
- IIBPTZJFUBIIIP-UHFFFAOYSA-N 6-bromo-2-(thiophen-2-ylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CC1=CC=CS1 IIBPTZJFUBIIIP-UHFFFAOYSA-N 0.000 description 1
- JXHUNLZWOKVGKL-UHFFFAOYSA-N 6-bromo-2-[(1-methylindol-3-yl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C12=CC=CC=C2N(C)C=C1CC1=NC2=NC=C(Br)C=C2N1 JXHUNLZWOKVGKL-UHFFFAOYSA-N 0.000 description 1
- KGAUFCCQJSPPCP-UHFFFAOYSA-N 6-bromo-2-[(2,4-difluorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC1=CC(F)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 KGAUFCCQJSPPCP-UHFFFAOYSA-N 0.000 description 1
- JGIXUKGUEBJPOF-UHFFFAOYSA-N 6-bromo-2-[(2-chlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC=C1CC1=NC2=NC=C(Br)C=C2N1 JGIXUKGUEBJPOF-UHFFFAOYSA-N 0.000 description 1
- RACILPSCYZHQAP-UHFFFAOYSA-N 6-bromo-2-[(3,4,5-trimethoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CC=2NC3=CC(Br)=CN=C3N=2)=C1 RACILPSCYZHQAP-UHFFFAOYSA-N 0.000 description 1
- OVCLGLRDDVOGBW-UHFFFAOYSA-N 6-bromo-2-[(3,4-dichlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 OVCLGLRDDVOGBW-UHFFFAOYSA-N 0.000 description 1
- SAKNSXHONINAKZ-UHFFFAOYSA-N 6-bromo-2-[(3-chlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(CC=2NC3=CC(Br)=CN=C3N=2)=C1 SAKNSXHONINAKZ-UHFFFAOYSA-N 0.000 description 1
- VLFHLXHIBQBOMW-UHFFFAOYSA-N 6-bromo-2-[(3-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CC=2NC3=CC(Br)=CN=C3N=2)=C1 VLFHLXHIBQBOMW-UHFFFAOYSA-N 0.000 description 1
- VYRSUOPTSZNUHP-UHFFFAOYSA-N 6-bromo-2-[(4-chlorophenoxy)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1OCC1=NC2=NC=C(Br)C=C2N1 VYRSUOPTSZNUHP-UHFFFAOYSA-N 0.000 description 1
- JGCQAISGBBJOEC-UHFFFAOYSA-N 6-bromo-2-[(4-chlorophenyl)methyl]-1,3-benzoxazole Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=CC=C(Br)C=C2O1 JGCQAISGBBJOEC-UHFFFAOYSA-N 0.000 description 1
- UYJBEKHKUXXJLQ-UHFFFAOYSA-N 6-bromo-2-[(4-chlorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 UYJBEKHKUXXJLQ-UHFFFAOYSA-N 0.000 description 1
- VMXPCZJLAOGEPP-UHFFFAOYSA-N 6-bromo-2-[(4-fluorophenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 VMXPCZJLAOGEPP-UHFFFAOYSA-N 0.000 description 1
- WDPFEOHNCJBHBE-UHFFFAOYSA-N 6-bromo-2-[(4-methoxy-3-methylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(C)C(OC)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 WDPFEOHNCJBHBE-UHFFFAOYSA-N 0.000 description 1
- NFSNRWXYAXOHRB-UHFFFAOYSA-N 6-bromo-2-[(4-methoxyphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 NFSNRWXYAXOHRB-UHFFFAOYSA-N 0.000 description 1
- KMCKDBKNSAGKPH-UHFFFAOYSA-N 6-bromo-2-[(4-methylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 KMCKDBKNSAGKPH-UHFFFAOYSA-N 0.000 description 1
- QAEKNDDDRQEOOM-UHFFFAOYSA-N 6-bromo-2-[(4-methylsulfanylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(SC)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 QAEKNDDDRQEOOM-UHFFFAOYSA-N 0.000 description 1
- RFRTYLOBLHQSGG-UHFFFAOYSA-N 6-bromo-2-[(4-phenylphenyl)methyl]-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1CC(C=C1)=CC=C1C1=CC=CC=C1 RFRTYLOBLHQSGG-UHFFFAOYSA-N 0.000 description 1
- HQDCCEZCMQRCGU-QHHAFSJGSA-N 6-bromo-2-[(e)-2-(2,4-difluorophenyl)ethenyl]-1,3-benzoxazole Chemical compound FC1=CC(F)=CC=C1\C=C\C1=NC2=CC=C(Br)C=C2O1 HQDCCEZCMQRCGU-QHHAFSJGSA-N 0.000 description 1
- WSDMJGSFMXZHRN-VMPITWQZSA-N 6-bromo-2-[(e)-2-(2-fluorophenyl)ethenyl]-1,3-benzoxazole Chemical compound FC1=CC=CC=C1\C=C\C1=NC2=CC=C(Br)C=C2O1 WSDMJGSFMXZHRN-VMPITWQZSA-N 0.000 description 1
- IYZXJTYRTABNLW-FPYGCLRLSA-N 6-bromo-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC=C(Br)C=C2O1 IYZXJTYRTABNLW-FPYGCLRLSA-N 0.000 description 1
- PNLQYHVCCKXEFF-RMKNXTFCSA-N 6-bromo-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1\C=C\C1=CC=CC=C1 PNLQYHVCCKXEFF-RMKNXTFCSA-N 0.000 description 1
- BYRUHLRSRXHDFM-VOTSOKGWSA-N 6-bromo-2-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1\C=C\C1=CC=CC=C1 BYRUHLRSRXHDFM-VOTSOKGWSA-N 0.000 description 1
- KWYZEHGCZWNKHL-UHFFFAOYSA-N 6-bromo-2-[2-(2-chlorophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 KWYZEHGCZWNKHL-UHFFFAOYSA-N 0.000 description 1
- BJHWUQMOZLCUQK-UHFFFAOYSA-N 6-bromo-2-[2-(2-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 BJHWUQMOZLCUQK-UHFFFAOYSA-N 0.000 description 1
- OBWIGRPADUOLNY-UHFFFAOYSA-N 6-bromo-2-[2-(3,4,5-trimethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CCC=2NC3=CC(Br)=CN=C3N=2)=C1 OBWIGRPADUOLNY-UHFFFAOYSA-N 0.000 description 1
- DCQMCXCFGRJDPY-UHFFFAOYSA-N 6-bromo-2-[2-(3,4-dichlorophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 DCQMCXCFGRJDPY-UHFFFAOYSA-N 0.000 description 1
- PCKSQCOVYXAWFV-UHFFFAOYSA-N 6-bromo-2-[2-(3,4-dimethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 PCKSQCOVYXAWFV-UHFFFAOYSA-N 0.000 description 1
- XSVPOGDUAIZEFF-UHFFFAOYSA-N 6-bromo-2-[2-(3-chlorophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound ClC1=CC=CC(CCC=2NC3=CC(Br)=CN=C3N=2)=C1 XSVPOGDUAIZEFF-UHFFFAOYSA-N 0.000 description 1
- MEHGUALSZQFVOT-UHFFFAOYSA-N 6-bromo-2-[2-(3-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=CC=CC(CCC=2NC3=CC(Br)=CN=C3N=2)=C1 MEHGUALSZQFVOT-UHFFFAOYSA-N 0.000 description 1
- CDHHTPSMCJZNKI-UHFFFAOYSA-N 6-bromo-2-[2-(4-butoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCCCC)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 CDHHTPSMCJZNKI-UHFFFAOYSA-N 0.000 description 1
- XCDQAKLNRYGKPF-UHFFFAOYSA-N 6-bromo-2-[2-(4-chlorophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(Cl)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 XCDQAKLNRYGKPF-UHFFFAOYSA-N 0.000 description 1
- JIBFSNATPVRABH-UHFFFAOYSA-N 6-bromo-2-[2-(4-ethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCC)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 JIBFSNATPVRABH-UHFFFAOYSA-N 0.000 description 1
- ABHGNSRZDUPBPH-UHFFFAOYSA-N 6-bromo-2-[2-(4-fluorophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(F)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 ABHGNSRZDUPBPH-UHFFFAOYSA-N 0.000 description 1
- OZMFPKOADDPBQI-UHFFFAOYSA-N 6-bromo-2-[2-(4-methoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 OZMFPKOADDPBQI-UHFFFAOYSA-N 0.000 description 1
- BXXVEMWYWWGFIS-UHFFFAOYSA-N 6-bromo-2-[2-(4-methylphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 BXXVEMWYWWGFIS-UHFFFAOYSA-N 0.000 description 1
- MJCMGILXUCMJID-UHFFFAOYSA-N 6-bromo-2-[2-(4-nitrophenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 MJCMGILXUCMJID-UHFFFAOYSA-N 0.000 description 1
- GZFOLEYAPCBEBJ-UHFFFAOYSA-N 6-bromo-2-[2-(4-propan-2-yloxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(C)C)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 GZFOLEYAPCBEBJ-UHFFFAOYSA-N 0.000 description 1
- CHIQSAZIUDTIHX-UHFFFAOYSA-N 6-bromo-2-[2-(4-propan-2-ylphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(C)C)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 CHIQSAZIUDTIHX-UHFFFAOYSA-N 0.000 description 1
- KRHOVPPPLIPNTN-UHFFFAOYSA-N 6-bromo-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CCC1=NC2=NC=C(Br)C=C2N1 KRHOVPPPLIPNTN-UHFFFAOYSA-N 0.000 description 1
- GJIHUTWNAXZASP-UHFFFAOYSA-N 6-bromo-2-[3-(2,2,2-trifluoroethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)COC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 GJIHUTWNAXZASP-UHFFFAOYSA-N 0.000 description 1
- DXTJODKLMVZLDL-UHFFFAOYSA-N 6-bromo-2-[3-(2,2-dimethylpropoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)(C)COC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 DXTJODKLMVZLDL-UHFFFAOYSA-N 0.000 description 1
- MXTUTUWSRXSHHT-UHFFFAOYSA-N 6-bromo-2-[3-(2-methoxyethoxy)phenyl]-1,3-benzoxazole Chemical compound COCCOC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 MXTUTUWSRXSHHT-UHFFFAOYSA-N 0.000 description 1
- IQFQABGXODUNMG-UHFFFAOYSA-N 6-bromo-2-[3-(2-methoxyethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound COCCOC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 IQFQABGXODUNMG-UHFFFAOYSA-N 0.000 description 1
- DUWAPUGRSLQSKJ-UHFFFAOYSA-N 6-bromo-2-[3-(2-morpholin-4-ylethoxy)phenyl]-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1OCCN1CCOCC1 DUWAPUGRSLQSKJ-UHFFFAOYSA-N 0.000 description 1
- NESFYCHYKJUTHL-UHFFFAOYSA-N 6-bromo-2-[3-(2-phenylethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=1)=CC=CC=1OCCC1=CC=CC=C1 NESFYCHYKJUTHL-UHFFFAOYSA-N 0.000 description 1
- OCYCVZBKDNQOJF-UHFFFAOYSA-N 6-bromo-2-[3-(3-methylbutoxy)phenyl]-1,3-benzoxazole Chemical compound CC(C)CCOC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 OCYCVZBKDNQOJF-UHFFFAOYSA-N 0.000 description 1
- PQGYGXOYIOHCAP-UHFFFAOYSA-N 6-bromo-2-[3-(3-methylbutoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)CCOC1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 PQGYGXOYIOHCAP-UHFFFAOYSA-N 0.000 description 1
- FUEHOWKLXRRUFC-UHFFFAOYSA-N 6-bromo-2-[3-(cyclohexylmethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=1)=CC=CC=1OCC1CCCCC1 FUEHOWKLXRRUFC-UHFFFAOYSA-N 0.000 description 1
- CXDNWRGABUODSB-UHFFFAOYSA-N 6-bromo-2-[3-(cyclopropylmethoxy)phenyl]-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1OCC1CC1 CXDNWRGABUODSB-UHFFFAOYSA-N 0.000 description 1
- KVXZYEBTSNVOJY-UHFFFAOYSA-N 6-bromo-2-[3-(trifluoromethoxy)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)OC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 KVXZYEBTSNVOJY-UHFFFAOYSA-N 0.000 description 1
- YIVDWEMZKKUGQY-UHFFFAOYSA-N 6-bromo-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)C1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 YIVDWEMZKKUGQY-UHFFFAOYSA-N 0.000 description 1
- HEATUHJQJOQOMM-UHFFFAOYSA-N 6-bromo-2-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2NC3=CC(Br)=CN=C3N=2)=C1 HEATUHJQJOQOMM-UHFFFAOYSA-N 0.000 description 1
- CTKLEXHVJJUCKU-UHFFFAOYSA-N 6-bromo-2-[3-(trifluoromethylsulfanyl)phenyl]-1,3-benzoxazole Chemical compound FC(F)(F)SC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 CTKLEXHVJJUCKU-UHFFFAOYSA-N 0.000 description 1
- AIZDOWCGJCQYRD-UHFFFAOYSA-N 6-bromo-2-[4-(2-methoxyethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OCCOC)=CC=C1C1=NC2=NC=C(Br)C=C2N1 AIZDOWCGJCQYRD-UHFFFAOYSA-N 0.000 description 1
- OQQBDOYMNUGCDG-UHFFFAOYSA-N 6-bromo-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(Br)C=C2N1 OQQBDOYMNUGCDG-UHFFFAOYSA-N 0.000 description 1
- CPHGTBGSDKCZNF-UHFFFAOYSA-N 6-bromo-2-[[4-(trifluoromethoxy)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 CPHGTBGSDKCZNF-UHFFFAOYSA-N 0.000 description 1
- MILZGXDISGXBCI-UHFFFAOYSA-N 6-bromo-2-[[4-(trifluoromethyl)phenyl]methyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CC1=NC2=NC=C(Br)C=C2N1 MILZGXDISGXBCI-UHFFFAOYSA-N 0.000 description 1
- IWNCFVXNXMQBCU-UHFFFAOYSA-N 6-bromo-2-cyclohexyl-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C1CCCCC1 IWNCFVXNXMQBCU-UHFFFAOYSA-N 0.000 description 1
- HVZPHUCKQYNMEA-UHFFFAOYSA-N 6-bromo-2-naphthalen-2-yl-1,3-benzoxazole Chemical compound C1=CC=CC2=CC(C3=NC4=CC=C(C=C4O3)Br)=CC=C21 HVZPHUCKQYNMEA-UHFFFAOYSA-N 0.000 description 1
- FMCHJRAOOGTHTN-UHFFFAOYSA-N 6-bromo-2-naphthalen-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC2=CC(C3=NC4=NC=C(C=C4N3)Br)=CC=C21 FMCHJRAOOGTHTN-UHFFFAOYSA-N 0.000 description 1
- YVZIBDQASKHGFK-UHFFFAOYSA-N 6-bromo-2-phenyl-1,3-benzoxazole Chemical compound O1C2=CC(Br)=CC=C2N=C1C1=CC=CC=C1 YVZIBDQASKHGFK-UHFFFAOYSA-N 0.000 description 1
- CLEWWDWKDXOTTG-UHFFFAOYSA-N 6-bromo-2-pyridin-2-yl-1h-imidazo[4,5-b]pyridine Chemical compound N1C2=CC(Br)=CN=C2N=C1C1=CC=CC=N1 CLEWWDWKDXOTTG-UHFFFAOYSA-N 0.000 description 1
- WDCDIXJSFUWSLM-UHFFFAOYSA-N 6-bromo-2-quinolin-6-yl-1,3-benzoxazole Chemical compound N1=CC=CC2=CC(C3=NC4=CC=C(C=C4O3)Br)=CC=C21 WDCDIXJSFUWSLM-UHFFFAOYSA-N 0.000 description 1
- KAEVHZSIYLATMK-UHFFFAOYSA-N 6-n-[bis(aziridin-1-yl)phosphoryl]-2-n,2-n,7-trimethylpurine-2,6-diamine Chemical compound C=12N(C)C=NC2=NC(N(C)C)=NC=1NP(=O)(N1CC1)N1CC1 KAEVHZSIYLATMK-UHFFFAOYSA-N 0.000 description 1
- DSCBIQJQXJOBAX-UHFFFAOYSA-N 6-naphthalen-1-yl-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 DSCBIQJQXJOBAX-UHFFFAOYSA-N 0.000 description 1
- BLJMJBJTRWAEBD-UHFFFAOYSA-N 6-naphthalen-1-yl-2-phenyl-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC=CC=C1C1=NC2=NC=C(C=3C4=CC=CC=C4C=CC=3)C=C2N1 BLJMJBJTRWAEBD-UHFFFAOYSA-N 0.000 description 1
- KOWRWHKOIHAIOW-UHFFFAOYSA-N 6-phenyl-2-(2-phenylcyclopropyl)-1h-imidazo[4,5-b]pyridine Chemical compound C1C(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)C1C1=CC=CC=C1 KOWRWHKOIHAIOW-UHFFFAOYSA-N 0.000 description 1
- YRBHDGKOTNLVBL-UHFFFAOYSA-N 6-phenyl-2-(2-phenylethyl)-1,3-benzoxazole Chemical compound N=1C2=CC=C(C=3C=CC=CC=3)C=C2OC=1CCC1=CC=CC=C1 YRBHDGKOTNLVBL-UHFFFAOYSA-N 0.000 description 1
- YNJUFBFOCSCEKO-UHFFFAOYSA-N 6-phenyl-2-(2-phenylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3C=CC=CC=3)C=C2NC=1CCC1=CC=CC=C1 YNJUFBFOCSCEKO-UHFFFAOYSA-N 0.000 description 1
- OSRBUYLZQDCTRD-UHFFFAOYSA-N 6-phenyl-2-(2-phenylpropyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1C(C)CC(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 OSRBUYLZQDCTRD-UHFFFAOYSA-N 0.000 description 1
- JKJNNVKAENTUIA-UHFFFAOYSA-N 6-phenyl-2-(2-thiophen-2-ylethyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CSC=1CCC(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 JKJNNVKAENTUIA-UHFFFAOYSA-N 0.000 description 1
- ULHXTJSMXZTCIX-UHFFFAOYSA-N 6-phenyl-2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridine Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 ULHXTJSMXZTCIX-UHFFFAOYSA-N 0.000 description 1
- LUEJJBLKJQYPFU-UHFFFAOYSA-N 6-phenyl-2-(5-phenylpentyl)-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC=CC=1CCCCCC(NC1=C2)=NC1=NC=C2C1=CC=CC=C1 LUEJJBLKJQYPFU-UHFFFAOYSA-N 0.000 description 1
- YWONRBQOHGOBHX-UHFFFAOYSA-N 6-phenyl-2-(phenylsulfanylmethyl)-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3C=CC=CC=3)C=C2NC=1CSC1=CC=CC=C1 YWONRBQOHGOBHX-UHFFFAOYSA-N 0.000 description 1
- BVERQZKPWFCZIQ-MDWZMJQESA-N 6-phenyl-2-[(e)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-benzoxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1\C=C\C1=NC2=CC=C(C=3C=CC=CC=3)C=C2O1 BVERQZKPWFCZIQ-MDWZMJQESA-N 0.000 description 1
- IMHQVXGQLQNCGO-SDNWHVSQSA-N 6-phenyl-2-[(e)-2-phenylethenyl]-1,3-benzoxazole Chemical compound N=1C2=CC=C(C=3C=CC=CC=3)C=C2OC=1/C=C/C1=CC=CC=C1 IMHQVXGQLQNCGO-SDNWHVSQSA-N 0.000 description 1
- QELQCLMPNDFIBP-VAWYXSNFSA-N 6-phenyl-2-[(e)-2-phenylethenyl]-1h-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC=C(C=3C=CC=CC=3)C=C2NC=1/C=C/C1=CC=CC=C1 QELQCLMPNDFIBP-VAWYXSNFSA-N 0.000 description 1
- MPBCTEXCCDXGMH-UHFFFAOYSA-N 6-phenyl-2-[2-(3,4,5-trimethoxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound COC1=C(OC)C(OC)=CC(CCC=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 MPBCTEXCCDXGMH-UHFFFAOYSA-N 0.000 description 1
- GNSAWMAYNKWRQK-UHFFFAOYSA-N 6-phenyl-2-[2-(4-propan-2-yloxyphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(C)C)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 GNSAWMAYNKWRQK-UHFFFAOYSA-N 0.000 description 1
- DULDDFADIDQWKZ-UHFFFAOYSA-N 6-phenyl-2-[2-(4-propan-2-ylphenyl)ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(C)C)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 DULDDFADIDQWKZ-UHFFFAOYSA-N 0.000 description 1
- ZBHOFYKPZHAQRT-UHFFFAOYSA-N 6-phenyl-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 ZBHOFYKPZHAQRT-UHFFFAOYSA-N 0.000 description 1
- NZIYMRUXPYYAJN-UHFFFAOYSA-N 6-phenyl-2-[3-(2,2,2-trifluoroethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)COC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 NZIYMRUXPYYAJN-UHFFFAOYSA-N 0.000 description 1
- MVAYDDIJSNSZDQ-UHFFFAOYSA-N 6-phenyl-2-[3-(2-phenylethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C=1C=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=CC=1OCCC1=CC=CC=C1 MVAYDDIJSNSZDQ-UHFFFAOYSA-N 0.000 description 1
- UOCJSNHHGKPJNG-UHFFFAOYSA-N 6-phenyl-2-[3-(trifluoromethyl)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)=C1 UOCJSNHHGKPJNG-UHFFFAOYSA-N 0.000 description 1
- SKQGSZJKENASKR-UHFFFAOYSA-N 6-phenyl-2-[4-(trifluoromethoxy)phenyl]-1h-imidazo[4,5-b]pyridine Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 SKQGSZJKENASKR-UHFFFAOYSA-N 0.000 description 1
- NKGPJODWTZCHGF-KQYNXXCUSA-N 6-thioinosinic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(S)=C2N=C1 NKGPJODWTZCHGF-KQYNXXCUSA-N 0.000 description 1
- UNQYAAAWKOOBFQ-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-8-[4-chloro-3-(trifluoromethoxy)phenoxy]-1-(3-hydroxypropyl)-3-methylpurine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=C(Cl)C(OC(F)(F)F)=C1 UNQYAAAWKOOBFQ-UHFFFAOYSA-N 0.000 description 1
- KABRXLINDSPGDF-UHFFFAOYSA-N 7-bromoisoquinoline Chemical compound C1=CN=CC2=CC(Br)=CC=C21 KABRXLINDSPGDF-UHFFFAOYSA-N 0.000 description 1
- NKGPJODWTZCHGF-UHFFFAOYSA-N 9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound OC1C(O)C(CO)OC1N1C(NC=NC2=S)=C2N=C1 NKGPJODWTZCHGF-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- KUSMIBXCRZTVML-PCCPLWKKSA-N Aclarubicin hydrochloride Chemical compound Cl.O([C@H]1[C@@H](O)C[C@@H](O[C@H]1C)O[C@H]1[C@H](C[C@@H](O[C@H]1C)O[C@H]1C[C@]([C@@H](C2=CC=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C21)C(=O)OC)(O)CC)N(C)C)[C@H]1CCC(=O)[C@H](C)O1 KUSMIBXCRZTVML-PCCPLWKKSA-N 0.000 description 1
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 229940127512 Androgen Synthesis Inhibitors Drugs 0.000 description 1
- 208000003120 Angiofibroma Diseases 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- PYMDEDHDQYLBRT-DRIHCAFSSA-N Buserelin acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 PYMDEDHDQYLBRT-DRIHCAFSSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- AOCCBINRVIKJHY-UHFFFAOYSA-N Carmofur Chemical compound CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O AOCCBINRVIKJHY-UHFFFAOYSA-N 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- RURLVUZRUFHCJO-UHFFFAOYSA-N Chromomycin A3 Natural products COC(C1Cc2cc3cc(OC4CC(OC(=O)C)C(OC5CC(O)C(OC)C(C)O5)C(C)O4)c(C)c(O)c3c(O)c2C(=O)C1OC6CC(OC7CC(C)(O)C(OC(=O)C)C(C)O7)C(O)C(C)O6)C(=O)C(O)C(C)O RURLVUZRUFHCJO-UHFFFAOYSA-N 0.000 description 1
- 241000744472 Cinna Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- JOJYUFGTMHSFEE-YONYXQDTSA-M Cytarabine ocfosphate Chemical compound [Na+].O[C@H]1[C@H](O)[C@@H](COP([O-])(=O)OCCCCCCCCCCCCCCCCCC)O[C@H]1N1C(=O)N=C(N)C=C1 JOJYUFGTMHSFEE-YONYXQDTSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 1
- ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 description 1
- 206010061825 Duodenal neoplasm Diseases 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- SAMRUMKYXPVKPA-VFKOLLTISA-N Enocitabine Chemical compound O=C1N=C(NC(=O)CCCCCCCCCCCCCCCCCCCCC)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 SAMRUMKYXPVKPA-VFKOLLTISA-N 0.000 description 1
- OBMLHUPNRURLOK-XGRAFVIBSA-N Epitiostanol Chemical compound C1[C@@H]2S[C@@H]2C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 OBMLHUPNRURLOK-XGRAFVIBSA-N 0.000 description 1
- VAPSMQAHNAZRKC-PQWRYPMOSA-N Epristeride Chemical compound C1C=C2C=C(C(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC2 VAPSMQAHNAZRKC-PQWRYPMOSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920003134 Eudragit® polymer Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 108091008794 FGF receptors Proteins 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- UKCVAQGKEOJTSR-UHFFFAOYSA-N Fadrozole hydrochloride Chemical compound Cl.C1=CC(C#N)=CC=C1C1N2C=NC=C2CCC1 UKCVAQGKEOJTSR-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 1
- 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
- BJJXHLWLUDYTGC-ANULTFPQSA-N Gestrinone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](CC)([C@](CC3)(O)C#C)C=C3)C3=C21 BJJXHLWLUDYTGC-ANULTFPQSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- JVHPTYWUBOQMBP-RVFAQHLVSA-N Idarubicin hydrochloride Chemical compound Cl.C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 JVHPTYWUBOQMBP-RVFAQHLVSA-N 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000005450 Maxillary Sinus Neoplasms Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 101710204212 Neocarzinostatin Proteins 0.000 description 1
- 102400000058 Neuregulin-1 Human genes 0.000 description 1
- 108090000556 Neuregulin-1 Proteins 0.000 description 1
- 229910021585 Nickel(II) bromide Inorganic materials 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000002471 Penile Neoplasms Diseases 0.000 description 1
- 108010057150 Peplomycin Proteins 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 206010034811 Pharyngeal cancer Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AHHFEZNOXOZZQA-ZEBDFXRSSA-N Ranimustine Chemical compound CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O AHHFEZNOXOZZQA-ZEBDFXRSSA-N 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 206010054184 Small intestine carcinoma Diseases 0.000 description 1
- OCOKWVBYZHBHLU-UHFFFAOYSA-N Sobuzoxane Chemical compound C1C(=O)N(COC(=O)OCC(C)C)C(=O)CN1CCN1CC(=O)N(COC(=O)OCC(C)C)C(=O)C1 OCOKWVBYZHBHLU-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 239000000317 Topoisomerase II Inhibitor Substances 0.000 description 1
- IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- BRDHGMMSHAGTIR-UHFFFAOYSA-N [2-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]phenyl] acetate Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C(=CC=CC=2)OC(C)=O)=C1 BRDHGMMSHAGTIR-UHFFFAOYSA-N 0.000 description 1
- VEGDKRDXKDWFIH-UHFFFAOYSA-N [4-(6-bromo-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]-phenylmethanone Chemical compound N1C2=CC(Br)=CN=C2N=C1C(C=C1)=CC=C1C(=O)C1=CC=CC=C1 VEGDKRDXKDWFIH-UHFFFAOYSA-N 0.000 description 1
- XVGDFFXKGJWLTE-UHFFFAOYSA-N [4-[6-(2-fluorophenyl)-1h-imidazo[4,5-b]pyridin-2-yl]phenyl]-phenylmethanone Chemical compound FC1=CC=CC=C1C1=CN=C(N=C(N2)C=3C=CC(=CC=3)C(=O)C=3C=CC=CC=3)C2=C1 XVGDFFXKGJWLTE-UHFFFAOYSA-N 0.000 description 1
- AVBLXTORTQHUIE-UHFFFAOYSA-N [4-[6-(furan-2-yl)-1h-imidazo[4,5-b]pyridin-2-yl]phenyl]-phenylmethanone Chemical compound C=1C=C(C=2NC3=CC(=CN=C3N=2)C=2OC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 AVBLXTORTQHUIE-UHFFFAOYSA-N 0.000 description 1
- BBEAZZAGJBIUCM-UHFFFAOYSA-N [4-[[2-(3-methoxyphenyl)-6-phenylimidazo[4,5-b]pyridin-1-yl]methyl]phenyl]-phenylmethanone Chemical compound COC1=CC=CC(C=2N(C3=CC(=CN=C3N=2)C=2C=CC=CC=2)CC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=C1 BBEAZZAGJBIUCM-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- GZOSMCIZMLWJML-VJLLXTKPSA-N abiraterone Chemical compound C([C@H]1[C@H]2[C@@H]([C@]3(CC[C@H](O)CC3=CC2)C)CC[C@@]11C)C=C1C1=CC=CN=C1 GZOSMCIZMLWJML-VJLLXTKPSA-N 0.000 description 1
- 229960000853 abiraterone Drugs 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- IYKJEILNJZQJPU-UHFFFAOYSA-N acetic acid;butanedioic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O IYKJEILNJZQJPU-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 229960004176 aclarubicin Drugs 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229960002692 allylestrenol Drugs 0.000 description 1
- 239000002160 alpha blocker Substances 0.000 description 1
- 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960000473 altretamine Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 229960002932 anastrozole Drugs 0.000 description 1
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 1
- KZOWNALBTMILAP-JBMRGDGGSA-N ancitabine hydrochloride Chemical compound Cl.N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 KZOWNALBTMILAP-JBMRGDGGSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940046836 anti-estrogen Drugs 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 125000001124 arachidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000003886 aromatase inhibitor Substances 0.000 description 1
- 229940046844 aromatase inhibitors Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- KLNFSAOEKUDMFA-UHFFFAOYSA-N azanide;2-hydroxyacetic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OCC(O)=O KLNFSAOEKUDMFA-UHFFFAOYSA-N 0.000 description 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 208000001119 benign fibrous histiocytoma Diseases 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical class OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- MMIMIFULGMZVPO-UHFFFAOYSA-N benzyl 3-bromo-2,6-dinitro-5-phenylmethoxybenzoate Chemical compound [O-][N+](=O)C1=C(C(=O)OCC=2C=CC=CC=2)C([N+](=O)[O-])=C(Br)C=C1OCC1=CC=CC=C1 MMIMIFULGMZVPO-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 229960000997 bicalutamide Drugs 0.000 description 1
- 208000026900 bile duct neoplasm Diseases 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 229960004395 bleomycin sulfate Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229960005064 buserelin acetate Drugs 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 108700002839 cactinomycin Proteins 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 description 1
- 235000008207 calcium folinate Nutrition 0.000 description 1
- 239000011687 calcium folinate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- KVUAALJSMIVURS-QNTKWALQSA-L calcium;(2s)-2-[[4-[[(6s)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate Chemical compound [Ca+2].C([C@@H]1N(C=O)C=2C(=O)N=C(NC=2NC1)N)NC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-QNTKWALQSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229960003261 carmofur Drugs 0.000 description 1
- 229960005243 carmustine Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- CSTBBLHIGMTEAZ-UHFFFAOYSA-N chloroform;ethyl acetate;hexane Chemical compound ClC(Cl)Cl.CCCCCC.CCOC(C)=O CSTBBLHIGMTEAZ-UHFFFAOYSA-N 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- NWSBNVVOFKKFNV-UHFFFAOYSA-N chloroform;oxolane Chemical compound ClC(Cl)Cl.C1CCOC1 NWSBNVVOFKKFNV-UHFFFAOYSA-N 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229960002436 cladribine Drugs 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate group Chemical group [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000004976 cyclobutylene group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004145 cyclopenten-1-yl group Chemical group [H]C1=C(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000004979 cyclopentylene group Chemical group 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000004980 cyclopropylene group Chemical group 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- 229960003901 dacarbazine Drugs 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000766 danazol Drugs 0.000 description 1
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 1
- 229960003109 daunorubicin hydrochloride Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 1
- 229950004203 droloxifene Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 201000000312 duodenum cancer Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 229950011487 enocitabine Drugs 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 229960003265 epirubicin hydrochloride Drugs 0.000 description 1
- 229950002973 epitiostanol Drugs 0.000 description 1
- 229950009537 epristeride Drugs 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 229960001766 estramustine phosphate sodium Drugs 0.000 description 1
- IIUMCNJTGSMNRO-VVSKJQCTSA-L estramustine sodium phosphate Chemical compound [Na+].[Na+].ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP([O-])([O-])=O)[C@@H]4[C@@H]3CCC2=C1 IIUMCNJTGSMNRO-VVSKJQCTSA-L 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- KPEUDULLQDHKAZ-VROINQGHSA-N ethinylestradiol sulfonate Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OS(=O)(=O)C(C)C)=CC=C3[C@H]21 KPEUDULLQDHKAZ-VROINQGHSA-N 0.000 description 1
- 229950001118 ethinylestradiol sulfonate Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 229960000752 etoposide phosphate Drugs 0.000 description 1
- LIQODXNTTZAGID-OCBXBXKTSA-N etoposide phosphate Chemical compound COC1=C(OP(O)(O)=O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 LIQODXNTTZAGID-OCBXBXKTSA-N 0.000 description 1
- 229960000255 exemestane Drugs 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229950011548 fadrozole Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000390 fludarabine Drugs 0.000 description 1
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
- 229960002074 flutamide Drugs 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical group C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- 229960004421 formestane Drugs 0.000 description 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- YAKWPXVTIGTRJH-UHFFFAOYSA-N fotemustine Chemical compound CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O YAKWPXVTIGTRJH-UHFFFAOYSA-N 0.000 description 1
- 229960004783 fotemustine Drugs 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229960005277 gemcitabine Drugs 0.000 description 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
- 229960004761 gestrinone Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000009217 hyperthermia therapy Methods 0.000 description 1
- 229960001176 idarubicin hydrochloride Drugs 0.000 description 1
- 229960001101 ifosfamide Drugs 0.000 description 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
- 229960003685 imatinib mesylate Drugs 0.000 description 1
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 229950008097 improsulfan Drugs 0.000 description 1
- DBIGHPPNXATHOF-UHFFFAOYSA-N improsulfan Chemical compound CS(=O)(=O)OCCCNCCCOS(C)(=O)=O DBIGHPPNXATHOF-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940084651 iressa Drugs 0.000 description 1
- 229960004768 irinotecan Drugs 0.000 description 1
- GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005932 isopentyloxycarbonyl group Chemical group 0.000 description 1
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 229960003881 letrozole Drugs 0.000 description 1
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 1
- 229960002293 leucovorin calcium Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- UGFHIPBXIWJXNA-UHFFFAOYSA-N liarozole Chemical compound ClC1=CC=CC(C(C=2C=C3NC=NC3=CC=2)N2C=NC=C2)=C1 UGFHIPBXIWJXNA-UHFFFAOYSA-N 0.000 description 1
- 229950007056 liarozole Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229960002247 lomustine Drugs 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 125000004401 m-toluyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C(*)=O 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229960001924 melphalan Drugs 0.000 description 1
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
- 229960000667 mepartricin Drugs 0.000 description 1
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- WVJKHCGMRZGIJH-UHFFFAOYSA-N methanetriamine Chemical compound NC(N)N WVJKHCGMRZGIJH-UHFFFAOYSA-N 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 238000006063 methoxycarbonylation reaction Methods 0.000 description 1
- ALPPGSBMHVCELA-WHUUVLPESA-N methyl (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1,3,5,7,9,13,37-heptahydroxy-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate methyl (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,7,9,13,37-heptahydroxy-17-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate Chemical compound CC1\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C(O[C@H]2[C@H]([C@@H](N)[C@H](O)[C@@H](C)O2)O)CC(O2)C(C(=O)OC)C(O)CC2(O)CC(O)CC(O)CC(O)CC(O)CC(=O)CC(O)CC(=O)OC1C(C)CCC(O)CC(=O)C1=CC=C(N)C=C1.C1=CC(NC)=CC=C1C(=O)CC(O)CCC(C)C1C(C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(O[C@H]2[C@H]([C@@H](N)[C@H](O)[C@@H](C)O2)O)CC(O2)C(C(=O)OC)C(O)CC2(O)CC(O)CC(O)CC(O)CC(O)CC(=O)CC(O)CC(=O)O1 ALPPGSBMHVCELA-WHUUVLPESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 190000032366 miboplatin Chemical compound 0.000 description 1
- 229950002777 miboplatin Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- 229960005485 mitobronitol Drugs 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 229960000350 mitotane Drugs 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 229960004169 mitoxantrone hydrochloride Drugs 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- NKFHKYQGZDAKMX-PPRKPIOESA-N n-[(e)-1-[(2s,4s)-4-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1h-tetracen-2-yl]ethylideneamino]benzamide;hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 NKFHKYQGZDAKMX-PPRKPIOESA-N 0.000 description 1
- PALXSMPBNMZFIA-UHFFFAOYSA-N n-[3-(6-bromo-1,3-benzoxazol-2-yl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2OC3=CC(Br)=CC=C3N=2)=C1 PALXSMPBNMZFIA-UHFFFAOYSA-N 0.000 description 1
- AFZUCGWYHIUXMN-UHFFFAOYSA-N n-[3-(6-bromo-1,3-benzoxazol-2-yl)phenyl]benzamide Chemical compound O1C2=CC(Br)=CC=C2N=C1C(C=1)=CC=CC=1NC(=O)C1=CC=CC=C1 AFZUCGWYHIUXMN-UHFFFAOYSA-N 0.000 description 1
- DUSANKLZYZNZDD-UHFFFAOYSA-N n-[3-[2-(3-propan-2-yloxyphenyl)-1h-imidazo[4,5-b]pyridin-6-yl]phenyl]acetamide Chemical compound CC(C)OC1=CC=CC(C=2NC3=CC(=CN=C3N=2)C=2C=C(NC(C)=O)C=CC=2)=C1 DUSANKLZYZNZDD-UHFFFAOYSA-N 0.000 description 1
- QIOVFSIQATWDHK-UHFFFAOYSA-N n-[3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 QIOVFSIQATWDHK-UHFFFAOYSA-N 0.000 description 1
- VABXMCZZEHAUQA-UHFFFAOYSA-N n-[3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]phenyl]benzamide Chemical compound C=1C=CC=CC=1C(=O)NC(C=1)=CC=CC=1C(OC1=C2)=NC1=CC=C2C1=CC=CO1 VABXMCZZEHAUQA-UHFFFAOYSA-N 0.000 description 1
- FACSYZXCRHSNGY-UHFFFAOYSA-N n-[3-[6-(furan-2-yl)-1,3-benzoxazol-2-yl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(C=2OC3=CC(=CC=C3N=2)C=2OC=CC=2)=C1 FACSYZXCRHSNGY-UHFFFAOYSA-N 0.000 description 1
- HCEXVWFQGFOFGG-UHFFFAOYSA-N n-[4-[2-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)ethyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CCC1=NC2=NC=C(C=3C=CC=CC=3)C=C2N1 HCEXVWFQGFOFGG-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229950007221 nedaplatin Drugs 0.000 description 1
- QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 description 1
- 125000005933 neopentyloxycarbonyl group Chemical group 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- IPLJNQFXJUCRNH-UHFFFAOYSA-L nickel(2+);dibromide Chemical compound [Ni+2].[Br-].[Br-] IPLJNQFXJUCRNH-UHFFFAOYSA-L 0.000 description 1
- 229960002653 nilutamide Drugs 0.000 description 1
- XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 description 1
- 229960001420 nimustine Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000005441 o-toluyl group Chemical group [H]C1=C([H])C(C(*)=O)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 229960002340 pentostatin Drugs 0.000 description 1
- FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 229950003180 peplomycin Drugs 0.000 description 1
- QIMGFXOHTOXMQP-GFAGFCTOSA-N peplomycin Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCCN[C@@H](C)C=1C=CC=CC=1)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1NC=NC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C QIMGFXOHTOXMQP-GFAGFCTOSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000004932 phenoxathinyl group Chemical group 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- YZCOASMZSTYENZ-UHFFFAOYSA-N phenyl-[4-(6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]methanone Chemical compound C=1C=C(C=2NC3=CC(=CN=C3N=2)C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 YZCOASMZSTYENZ-UHFFFAOYSA-N 0.000 description 1
- AQCYJQQFVWOHDA-UHFFFAOYSA-N phenyl-[4-(6-thiophen-2-yl-1h-imidazo[4,5-b]pyridin-2-yl)phenyl]methanone Chemical compound C=1C=C(C=2NC3=CC(=CN=C3N=2)C=2SC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 AQCYJQQFVWOHDA-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960000952 pipobroman Drugs 0.000 description 1
- NJBFOOCLYDNZJN-UHFFFAOYSA-N pipobroman Chemical compound BrCCC(=O)N1CCN(C(=O)CCBr)CC1 NJBFOOCLYDNZJN-UHFFFAOYSA-N 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229940034049 polysaccharide-k Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960001586 procarbazine hydrochloride Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- XYWJNTOURDMTPI-UHFFFAOYSA-N procodazole Chemical compound C1=CC=C2NC(CCC(=O)O)=NC2=C1 XYWJNTOURDMTPI-UHFFFAOYSA-N 0.000 description 1
- 229950000989 procodazole Drugs 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical group CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 229950007401 pumitepa Drugs 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 229960004622 raloxifene Drugs 0.000 description 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
- 229960002185 ranimustine Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 229950010372 sobuzoxane Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000009120 supportive therapy Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940095374 tabloid Drugs 0.000 description 1
- FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 description 1
- 229960003454 tamoxifen citrate Drugs 0.000 description 1
- 229960003198 tamsulosin hydrochloride Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229960001674 tegafur Drugs 0.000 description 1
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 1
- 229960004964 temozolomide Drugs 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- 229960001278 teniposide Drugs 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M thiocyanate group Chemical group [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000005505 thiomorpholino group Chemical group 0.000 description 1
- 229960001196 thiotepa Drugs 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960000303 topotecan Drugs 0.000 description 1
- 229960004167 toremifene citrate Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 description 1
- 229950001353 tretamine Drugs 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229960000875 trofosfamide Drugs 0.000 description 1
- UMKFEPPTGMDVMI-UHFFFAOYSA-N trofosfamide Chemical compound ClCCN(CCCl)P1(=O)OCCCN1CCCl UMKFEPPTGMDVMI-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229950009811 ubenimex Drugs 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- KDQAABAKXDWYSZ-PNYVAJAMSA-N vinblastine sulfate Chemical compound OS(O)(=O)=O.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 KDQAABAKXDWYSZ-PNYVAJAMSA-N 0.000 description 1
- 229960004982 vinblastine sulfate Drugs 0.000 description 1
- AQTQHPDCURKLKT-JKDPCDLQSA-N vincristine sulfate Chemical compound OS(O)(=O)=O.C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 AQTQHPDCURKLKT-JKDPCDLQSA-N 0.000 description 1
- 229960002110 vincristine sulfate Drugs 0.000 description 1
- 229960005212 vindesine sulfate Drugs 0.000 description 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 1
- 229960002066 vinorelbine Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 229950009268 zinostatin Drugs 0.000 description 1
- 229950009233 zinostatin stimalamer Drugs 0.000 description 1
- FYQZGCBXYVWXSP-STTFAQHVSA-N zinostatin stimalamer Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1OC1C/2=C/C#C[C@H]3O[C@@]3([C@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(C)C=CC2=C(C)C=C(OC)C=C12 FYQZGCBXYVWXSP-STTFAQHVSA-N 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002341477A JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001359753 | 2001-11-26 | ||
JP2001-359753 | 2001-11-26 | ||
JP2002341477A JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003221386A true JP2003221386A (ja) | 2003-08-05 |
JP2003221386A5 JP2003221386A5 (enrdf_load_stackoverflow) | 2005-09-08 |
Family
ID=27759288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002341477A Ceased JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003221386A (enrdf_load_stackoverflow) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008528578A (ja) * | 2005-01-28 | 2008-07-31 | ダエウン ファーマシューティカル カンパニー リミテッド | 新規のベンゾイミダゾール誘導体及びこれを含む薬剤学的組成物 |
US8436012B2 (en) | 2008-08-05 | 2013-05-07 | Daiichi Sankyo Company, Limited | Imidazopyridin-2-one derivatives |
JP2014502988A (ja) * | 2011-01-21 | 2014-02-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン |
JP2014101359A (ja) * | 2012-10-26 | 2014-06-05 | Mie Univ | がん細胞阻害薬、がん幹細胞検出用プローブ |
JP2014143413A (ja) * | 2012-12-28 | 2014-08-07 | Dow Global Technologies Llc | 電子薄膜および電子デバイスのためのキノリン−ベンゾオキサゾール由来化合物 |
JP2015044854A (ja) * | 2007-12-07 | 2015-03-12 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | シクロアルキルカルボキサミドピリジン安息香酸を生成するためのプロセス |
JP2015096550A (ja) * | 2011-02-25 | 2015-05-21 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病剤として有用な新規環状アザベンゾイミダゾール誘導体 |
JP2015193639A (ja) * | 2005-03-25 | 2015-11-05 | サーフェイス ロジックス,インコーポレイティド | 薬物動態的改良型化合物 |
JP2016539979A (ja) * | 2013-12-09 | 2016-12-22 | ユーシービー バイオファルマ エスピーアールエル | Tnf活性のモジュレーターとしてのイミダゾピリジン誘導体 |
US9725440B2 (en) | 2007-05-09 | 2017-08-08 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
US9751890B2 (en) | 2008-02-28 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Heteroaryl derivatives as CFTR modulators |
US9840499B2 (en) | 2007-12-07 | 2017-12-12 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
US10076513B2 (en) | 2010-04-07 | 2018-09-18 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
US10231932B2 (en) | 2013-11-12 | 2019-03-19 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
US10302602B2 (en) | 2014-11-18 | 2019-05-28 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
US10626111B2 (en) | 2004-01-30 | 2020-04-21 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
CN116903554A (zh) * | 2023-09-13 | 2023-10-20 | 北京科翔中升医药科技有限公司 | Vista和pd-1/pd-l1双靶点小分子抑制剂及其制备方法和用途 |
-
2002
- 2002-11-25 JP JP2002341477A patent/JP2003221386A/ja not_active Ceased
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10626111B2 (en) | 2004-01-30 | 2020-04-21 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
JP2008528578A (ja) * | 2005-01-28 | 2008-07-31 | ダエウン ファーマシューティカル カンパニー リミテッド | 新規のベンゾイミダゾール誘導体及びこれを含む薬剤学的組成物 |
JP2015193639A (ja) * | 2005-03-25 | 2015-11-05 | サーフェイス ロジックス,インコーポレイティド | 薬物動態的改良型化合物 |
US11084804B2 (en) | 2005-11-08 | 2021-08-10 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US9725440B2 (en) | 2007-05-09 | 2017-08-08 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
US9776968B2 (en) | 2007-12-07 | 2017-10-03 | Vertex Pharmaceuticals Incorporated | Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
US12065432B2 (en) | 2007-12-07 | 2024-08-20 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
US10597384B2 (en) | 2007-12-07 | 2020-03-24 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
US9840499B2 (en) | 2007-12-07 | 2017-12-12 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
JP2015044854A (ja) * | 2007-12-07 | 2015-03-12 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | シクロアルキルカルボキサミドピリジン安息香酸を生成するためのプロセス |
US9751890B2 (en) | 2008-02-28 | 2017-09-05 | Vertex Pharmaceuticals Incorporated | Heteroaryl derivatives as CFTR modulators |
US8785438B2 (en) | 2008-08-05 | 2014-07-22 | Daiichi Sankyo Company, Limited | Imidazopyridin-2-one derivatives |
US8436012B2 (en) | 2008-08-05 | 2013-05-07 | Daiichi Sankyo Company, Limited | Imidazopyridin-2-one derivatives |
US10076513B2 (en) | 2010-04-07 | 2018-09-18 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
US11052075B2 (en) | 2010-04-07 | 2021-07-06 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof |
JP2014502988A (ja) * | 2011-01-21 | 2014-02-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン |
JP2015096550A (ja) * | 2011-02-25 | 2015-05-21 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病剤として有用な新規環状アザベンゾイミダゾール誘導体 |
JP2014101359A (ja) * | 2012-10-26 | 2014-06-05 | Mie Univ | がん細胞阻害薬、がん幹細胞検出用プローブ |
US10220024B2 (en) | 2012-10-26 | 2019-03-05 | Canon Kabushiki Kaisha | Method of inhibiting cancer cell, method for detecting cancer cell, and system for detecting cancer cell |
JP2014143413A (ja) * | 2012-12-28 | 2014-08-07 | Dow Global Technologies Llc | 電子薄膜および電子デバイスのためのキノリン−ベンゾオキサゾール由来化合物 |
US10231932B2 (en) | 2013-11-12 | 2019-03-19 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
JP2016539979A (ja) * | 2013-12-09 | 2016-12-22 | ユーシービー バイオファルマ エスピーアールエル | Tnf活性のモジュレーターとしてのイミダゾピリジン誘導体 |
US10302602B2 (en) | 2014-11-18 | 2019-05-28 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
CN116903554A (zh) * | 2023-09-13 | 2023-10-20 | 北京科翔中升医药科技有限公司 | Vista和pd-1/pd-l1双靶点小分子抑制剂及其制备方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7622479B2 (en) | Bicyclic derivative, its production and use | |
KR102593742B1 (ko) | 인다졸-3-카복사마이드를 사용하는 방법 및 wnt/b-카테닌 신호전달 경로 억제제로서의 그들의 용도 | |
JP2003221386A (ja) | 二環性誘導体、その製造法およびその用途 | |
TWI699359B (zh) | 4h-吡咯[3,2-c]吡啶-4-酮衍生物 | |
JP6378409B2 (ja) | 1H−ピラゾロ[3,4−b]ピリジンおよびそれらの治療的使用 | |
ES2708211T3 (es) | 3-amino-1,5,6,7-tetrahidro-4H-indol-4-onas | |
JP6401345B2 (ja) | Wntシグナル伝達経路のインダゾール阻害剤およびそれらの治療的使用 | |
JP6355648B2 (ja) | Wntシグナル伝達経路の3−(ベンゾイミダゾール−2−イル)−インダゾール阻害剤およびそれらの治療的使用 | |
JP6181862B2 (ja) | ピラゾロピロリジン誘導体および疾患の処置におけるその使用 | |
JP6290203B2 (ja) | ヘッジホッグ経路阻害剤としてのn−(3−ヘテロアリールアリール)−4−アリールアリールカルボキサミド及び類似体並びにそれらの使用 | |
US20110052562A1 (en) | Benzimidazoles and analogs as rho kinase inhibitors | |
US20070010537A1 (en) | Fused pyramidine derivative and use thereof | |
IL302807A (en) | Gcn2 and perk kinase inhibitors and methods of use thereof | |
US20040072876A1 (en) | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof | |
WO2004060362A2 (en) | COMPOSITIONS AND METHODS FOR INHIBITING TGF-β | |
KR20050098286A (ko) | 사이클릭 우레아 유도체, 이의 제조방법 및 키나제억제제로서의 이의 약제학적 용도 | |
CN104817497B (zh) | 一种炔代喹啉衍生物及其制备方法和用途 | |
EP3587406A1 (en) | 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer | |
EP0927166A1 (en) | Amides as npy5 receptor antagonists | |
EA029892B1 (ru) | Азотсодержащее гетероциклическое соединение | |
JP2003321472A (ja) | Grk阻害剤 | |
WO2008109613A1 (en) | Benzo[c][2,7]naphthyridine derivatives, and their use as kinase inhibitors | |
WO2005019188A1 (ja) | 縮合ピリミジン誘導体およびその用途 | |
JP2000143635A (ja) | 血管新生阻害剤 | |
JP4921168B2 (ja) | ベンジルベンズイミダゾリル誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050311 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050311 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081111 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090107 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090107 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090217 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090408 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090630 |
|
A045 | Written measure of dismissal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20091027 |